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Introduction 
In our society, the ability to hear is taken for granted as hearing is an essential part of 
oral communication. However, millions of people throughout the world are affected by the 
very common sensory disability that hearing impairment is. The consequences of this 
disorder are still highly underestimated. Indeed, difficulties in hearing are not life threatening, 
but they may drastically limit the quality of life of those affected, as they may impose severe 
social and professional burdens. During the past few decades, this last notion has become 
increasingly important, especially since profound changes in the structure of our society have 
resulted in a major shift from non-communicative labor to mainly communicative professions. 
The causes of hearing impairment are mostly multifactorial, but with better control of 
environmental and infectious factors, the portion attributed to heredity steadily increases. It 
was Hartmann who inspired Politzer to acknowledge that genetics play a role in the etiology 
of hearing impairment.12 This notion became generally accepted thanks to the publication of 
the second edition of Politzer's Lehrbuch der Ohrenheilkunde (1887). Soon after, Mendel's 
laws were rediscovered.3 They provided insight into the various patterns of inheritance, but it 
remained for Watson and Crick to uncover the structure of our genetic material in 1953.4 Still, 
it took until the early nineties before the first gene responsible for hearing impairment was 
found. 
Hereditary hearing impairment may be of a conductive or mixed nature, but in most 
cases it is sensorineural in origin. About one child in a thousand is born with prelmgual 
hearing loss and in at least half of these cases the cause is inherited.56 The pattern of 
inheritance is autosomal recessive in about 75% of cases, autosomal dominant in about 
20%, X-lmked in approximately 5%, and mitochondrial in less than 1%.5"θ Non-syndromic 
forms outnumber syndromic forms of hearing impairment with regard to the frequency of 
occurrence, since the former account for approximately 70% of genetic hearing impairment.9 
Late onset hearing impairment is more frequent, but also the least understood. The 
prevalence of age-related hereditary hearing impairment has been roughly determined at 
3.2/1000.6 On the whole, however, the prevalence of hereditary hearing impairment is 
considered to be rather underestimated. 
As syndromic hearing impairment is more easily distinguishable on the basis of 
associated features, focus was first on syndromic forms. Our knowledge of especially the 
non-syndromic genetic forms has expanded tremendously since 1992, when the first genetic 
studies on the subject were performed. Previously, differentiation took place on the basis of 
rather superficial clinical descriptions.9"'" In the case of autosomal dominant, non-syndromic 
hearing loss for example, only 8 types could be recognized (Table 1), while nowadays 39 
different forms are distinguished (Table 3). Moreover, some non-syndromic forms can be 
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hard to distinguish from hearing impairment caused by environmental factors or age All this 
changed with the development of genetic linkage techniques Gene linkage studies in large 
families enabled us to discriminate between types of hearing impairment that could not be 
discerned in the past These genetic linkage techniques are applied to determine a region on 
the genome, a so-called locus, in which the disease-causing gene is situated The different 
loci for non-syndromic forms of deafness are called DFN (DeaFNess) and are numbered in 
chronological order of discovery According to the mode of inheritance a locus is designated 
DFNA (autosomal dominant), DFNB (autosomal recessive) or DFN (X-lmked) 
Table 1 Eight clinical types of autosomal dominant, non-syndromic sensorineural hearing loss 
according to Gorlm et al '0 
Clinical types of autosomal dominant, non-syndromic hearing loss according 
to Gorlm et al ' 0 
1 Congenital severe sensorineural hearing loss 
2 Congenital low-frequency sensorineural heanng loss 
3 Progressive low-frequency sensorineural hearing loss with childhood onset 
4 Mid-frequency sensorineural heanng loss 
5 Progressive sensorineural heanng loss 
6 Progressive mixed hearing loss 
7 Unilateral sensorineural hearing loss 
θ Progressive vestibulo-cochlear dysfunction and sensorineural hearing loss 
Up until now, hearing impairment genes have been identified by positional cloning or 
by the positional candidate gene approach Both techniques are preceded by linkage 
analysis, so that an initial localization of the gene of interest is already known The positional 
cloning strategy uses linkage analysis in large families to locate the mutation that 
compromises the normal function of the gene, and this mutation is thus responsible for the 
hearing impairment An attempt is made to find the implicated region of DNA by means of 
several markers for which the localization on the chromosome is known By doing this, one 
tries to identify a marker that is common for all affected individuals A computer program 
calculates the probability that a marker is linked to a certain locus (LOD score) The larger 
the family and the more markers used, the more likely it will be that the mutated gene is 
located accurately Nowadays, a minimum of ten affected members per family is required to 
allow successful linkage Once the disease gene is mapped, this gene needs to be cloned 
and finally the gene product can be identified In most instances, after the identification of a 
deafness gene, there still remains a world of understanding and the overall process may 
require several years 
12 
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The positional candidate gene approach, on the other hand, uses -after linkage- the 
phenotype to predict the genotype and is therefore dependent on previously acquired 
knowledge. This method is gaming interest thanks to recent achievements in the Human 
Genome Project and, off course, thanks to our increasing understanding of hereditary 
hearing impairment. Indeed, knowledge about one gene can trigger the identification of 
another. In addition, since the auditory systems and genetic material of mice and man are 
quite similar, mouse models have proven their value in selecting candidate genes. 
After finding the gene defect in a mutant strain of deaf mice, the causative gene is 
isolated through comparison of human and mouse genes. Candidate genes for deafness 
may also be identified by a tissue-specific approach. For that purpose libraries of human fetal 
cochlear cDNA were constructed.12 These libraries contain DNA which provides copies of 
messenger RNA, which in turn, codes for genes expressed in the human developing 
cochlea. They are believed to greatly facilitate the process of gene identification in the future. 
Table 2 summarizes the loci and genes known to be responsible for the most frequent 
forms of syndromic hearing impairment. Table 3 gives an overview of all autosomal dominant 
non-syndromic hearing impairment loci and genes identified so far. Autosomal recessive 
non-syndromic hearing impairment loci and genes are shown in Table 4 and those known to 
be responsible for X-linked non-syndromic hearing impairment are listed in Table 5. 
Over the last few years mitochondrial defects have also been associated with hearing loss 
(Table 6) An updated review of most syndromic and all non-syndromic loci and genes 
involved in hereditary hearing impairment can be found on the Hereditary Hearing Loss 
Homepage.149 
We now understand a good deal about the nature of mutations in some genes 
involved in hearing impairment, but we still have little idea about how the molecular defect is 
expressed into the tissue and into the clinical phenotype. Table 7 lists the criteria on which 
the clinical classification of hearing impairment is based.150 In the meantime more extensive 
testing (e.g. speech recognition scores, vestibular testing,...) has revealed other means of 
classification. It is to be expected that the more thorough phenotype studies are carried out, 
the more criteria will emerge. Since phenotypic expression of hearing impairment can be 
very similar for different genotypes, it is imperative to outline all clinical features meticulously. 
By doing so, an attempt is made to determine whether the phenotype reflects the nature and 
position of the mutation, thus trying to establish a genotype-phenotype correlation. 
Furthermore, phenotype studies contribute to genetic linkage techniques by identifying the 
phenocopies in a family. Phenocopies are subjects with a clinical presentation (almost) 
identical to carriers, but due to a cause other than the mutation present in these carriers. On 
the other hand, a person shown to carry the particular mutation may exhibit a different kind of 
13 
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hearing impairment, or may even exhibit no hearing impairment whatsoever (i.e. show non-
penetrance). Indeed, a specific mutation in a given gene can lead to a wide variety of 
phenotypes. This phenotypic variability can be attributed to environmental factors, genetic 
background or the genotype at another locus. The latter is referred to as a modifier gene and 
can act either as an enhancer or a suppressor of the hearing impairment.151 It was only 
recently that the first of such genes was localized152 and many are expected to follow. 
Table 2. Chromosomal localizations and genes associated with the most frequent forms of syndromic 
hearing impairment. 
Syndrome 
Alport 
Branchio-Oto-Renal 1 
(BOR) 11 
Localization 
Xq22 
2q36-37 
8q13 3 
1q31 
Jervell and Lange-Nielsen 11p15.5 
(JLNS) 
Nome 
Pendred (PDS) 
Stickler (STL) 1 
2 
3 
Treacher Collins (TCOF) 
Usher (USH) 1A 
1B 
1C 
ID 
1E 
1F 
2A 
2B 
2C 
3 
Waardenburg (WS) I 
II 
III 
IV 
21q22 1-2 
Xp11.3 
7q21-34 
12q13 11-12 
6p21 3 
1p21 
5q32-33 1 
14q32 
11q13.5 
11p151 
10q 
21q 
10 
1q41 
3p23-24 2 
5q14.3-21.3 
3q21-25 
2q35 
3p14 1-12 3 
2q35 
13q22 
20q13 2-3 
22q13 
Gene 
COL4A5 
COL4A3 
COL4A4 
EYA1 
KvLQTI 
KCNE1 
Nornn 
PDS 
COL2A1 
COL11A2 
COL11A1 
TCOF1 
MY07A 
USH1C 
CDH23 
USH2A 
PAX3 
MITF 
PAX3 
EDNRB 
EDN3 
SOX10 
Reference 
Barker'3 
Mochizuki" 
Abdelhak'5 
Kumar16 
Neyroud'7 
Tyson'8, Schulze-Bahr'9 
Berger20, Chen2' 
Everett22 
Williams23 
Vikkula24 
Richards25 
Dixon26 
Kaplan27 
Weil28 
Smith29, Verpy30, Bitner-Glmdzicz31 
Wayne32, Bork33, Bolz34 
Chaib35 
Wayne36 
Kimberlmg37, Eudy36 
Hmam39 
Pieke-Dahl40 
Sankila4' 
Tassabehji42 
Tassabehji43 
Hoth44 
Attie45 
Edery46 
Pingault47 
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Table 3: Loci, chromosomal localizations and genes associated with autosomal dominant, non-
syndromic hearing impairment. 
Locus 
DFNA1 
DFNA2 
DFNA3 
DFNA4 
DFNA5 
DFNA6 
DFNA7 
DFNA8/12 
DFNA9 
DFNA10 
DFNA11 
DFNA12 
DFNA13 
DFNA14 
DFNA15 
DFNA16 
DFNA17 
DFNA18 
DFNA19 
DFNA20 
DFNA21 
DFNA22 
DFNA23 
DFNA24 
DFNA25 
DFNA26 
DFNA27 
DFNA28 
DFNA29 
DFNA30 
DFNA31 
DFNA32 
DFNA33 
DFNA34 
DFNA35 
DFNA36 
DFNA37 
DFNA38 
DFNA39 
DFNA40 
Localization 
5q31 
1p34 
13q12 
19q13 
7p15 
4p16 3 
1q21-23 
11q22-24 
14q12-13 
6q22-23 
11q12 3-21 
11q22-24 
6p21 
4p16 
5q31 
2q24 
22q 
3q22 
10 
17q25 
14q21-22 
4q 
12q21-24 
17q25 
4q12 
8q22 
15q26 
11p15 
1q44 
9q 13-21 
1p21 
4q21 
Gene 
HDIA1 
GJB3 (Cx31) 
KCNQ4 
GJB2 (Cx26) 
GJB6 (Cx30) 
DFNA5 
TECTA 
COCH 
EYA4 
MY07A 
TECTA 
COL11A2 
POU4F3 
MYH9 
Reference 
Leon48, Lynch49 
Coucke50, Xia5' 
Kubisch52 
Chaib53, Denoyelle54 
Gnta55 
Chen56 
Van Camp57, Van Laer58 
Lesperance59 
Fagerheim60 
Kirschhofer61, Verhoeven62 
Manohs63, Robertson64 
O'Neill65, Wayne66 
Tamagawa67, Liu68 
Verhoeven6269 
Brown70, McGuirt71 
Van Camp72 
Vahava73 
Fukushima74 
Lalwam75 76 
Boensch77 
Green78 
Morell79 
reserved 
reserved 
Salam80 
Hafner81 
Greene62 
Yang83 
Fndell84 
Anderson85 
reserved 
Mangino86 
withdrawn 
U87 
reserved 
Kurima86 
reserved 
Kurima88 
Talebizadeh69 
reserved 
reserved 
reserved 
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Table 4- Loci, chromosomal localizations and genes associated with autosomal recessive, non-
syndromic hearing impairment. 
Locus 
DFNB1 
DFNB2 
DFNB3 
DFNB4 
DFNB5 
DFNB6 
DFNB7 
DFNB8 
DFNB9 
DFNB10 
DFNB11 
DFNB12 
DFNB13 
DFNB14 
DFNB15 
DFNB16 
DFNB17 
DFNB18 
DFNB19 
DFNB20 
DFNB21 
DFNB22 
DFNB23 
DFNB24 
DFNB25 
DFNB26 
DFNB27 
DFNB28 
DFNB29 
DFNB30 
Localization 
13q12 
11q135 
17p11 2 
7q31 
14q12 
3p14-21 
9q 13-21 
21q22 
2p22-23 
21q22 3 
9q13-21 
10q21-22 
7q34-36 
7q31 
3q21-25' 
19p13* 
15q21-22 
7q31 
11p14-15.1 
18p11 
11q25-qter 
11q 
10p11 2-q21 
11q23 
4p15 3-q12 
4q31 
2q23-31 
22q13 
21q22 
10p 
* Both loci revealed similar LOD scores 
Gene 
GJB2 (Cx26) 
MY07A 
MY015 
PDS 
TMPRSS3 
OTOF 
TMPRSS3 
CDH23 
TECTA 
Reference 
Guilford90, Kelsell91 
Guilford92, Liu93, Weil94 
Friedman95, Wang96 
Baldwin97, Li98 
Fukushima" 
Fukushima100 
Jam101 
Veske102, Scott103 
Chaib104, Yasunaga105 
Bonné-Tamir106, Scott107 
Scott107 
Chaib108, Bork33 
Mustapha109 
Mustapha110 
Chen111 
Campbell112 
Greinwald113 
Jam114 
Green"5 
Moymhan116 
Mustapha117 
reserved 
reserved 
reserved 
reserved 
Riazuddm16 
Pulleyn118 
Walsh119 
Wilcox120 
reserved 
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Table 5 Loci, chromosomal localizations and genes associated with X-lmked, non-syndromic hearing 
impairment 
Locus 
DFN1* 
DFN2 
DFN3 
DFN4 
DFN5 
DFN6 
DFN7 
DFN8 
* later recogn zed 
Localization 
Xq22 
Xq22 
Xq21 1 
Xp21 2 
Xp22 
as syndromic 
Gene 
DDP 
POU3F4 
Reference 
Tranebjaerg'^Jm122 
Tyson'23 
de Kok124 
Lalwani125 
withdrawn 
del Castillo126 
withdrawn 
reserved 
Table 6 Mitochondrial mutations associated with non-syndromic and syndromic hearing impairment 
Mitochondrial mutations associated with syndromic hearing Impairment 
Syndrome 
KSS (Kearns-Sayre Syndrome) 
MELAS (Mitochondrial Encephalopathy, 
Gene 
several 
tRNALeu 
Lactic Acidosis and Stroke-like episodes) 
MERRF (Myoclonic Epilepsy and Ragged Red 
Fibers) 
MIDD (Maternally Inherited Diabetes and 
Deafness) 
tRNALys 
tRNALeu 
tRNALys 
tRNAGIu, 
Progressive myoclonic epilepsy, ataxia and hearing tRNASer 
impairment 
Mitochondrial mutations associated with non 
Gene 
12SrRNA 
TRNASer 
Reference 
Moraes127 
Goto128 
Shotfner129, Zeviam130 
van den Ouweland131 
Kameoka132 
Hao133, Ballmger134 
Jaksch135 
-syndromic hearing impairment 
Reference 
Prezant136, Usami137, Estivili138 
•Reid139, -Fischel-Ghodsian140, 'Sevior141 
'Tiranti142, 'Jaksch135143, 'Schuelke144, Verhoeven145 
Hutchm146, Friedman 
' additional symptoms were present in some patients 
147
, Sue148 
17 
Chapter 1 
Table Τ Criteria to classify hearing impairment according to Parvmg et al. 
Criteria to classify hearing impairment 
according to Parving et al.1 5 0 
Mode of gene transmission 
Severity 
Age at onset 
Unilateral / bilateral 
Stationary / progressive 
Syndromic/ non-syndromic 
Frequencies involved 
Type 
Chromosome / gene locus if known 
Another aspect of hereditary hearing impairment that needs clarification is the 
prevalence of its specific types. At present, only a handful of families are linked to each 
region. A major exception is Connexin26 (GJB2)-related hearing impairment. This gene is 
responsible for approximately 50% of prelingual, non-syndromic, recessive hearing loss with 
a carrier rate varying from 2 to nearly 5% depending on ethnic group.153'15'" In Caucasians, 
the causative factor usually is a single mutation (35delG) and it has become common 
practice to screen for this defect. The story of Cx26 is considered a true success among 
deafness-genes. Among the DFNA-types, the only notable exceptions are DFNA2/KC/\/Q4 
(see below) and DFNAg/COCH.155157 
Recent developments in the identification of genes for inherited hearing impairment 
have also shown this disorder to be markedly genetically heterogeneous (Figure 1 and 2). 
This explains why some loci contain several genes and others have overlapping genetic 
intervals that may harbor only a single gene. Moreover, different mutations in the same gene 
can produce a broad spectrum of phenotypes while some genes are implicated in both 
syndromic and non-syndromic hearing impairment. The genetic approach is proving to be a 
powerful tool in unraveling the molecular basis of hearing. Still, there are probably many 
more genes awaiting identification. The auditory function is an extremely complex process 
and phenotypic and genetic heterogeneity must certainly be examined further to advance our 
understanding of it. 
1Θ 
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Current project and aim of study 
This study is part of a long-standing tradition, present at the Nijmegen ENT 
Department of performing research into hereditary hearing impairment. Focus in this thesis is 
on the clinical presentation or phenotype, in relation to the genotype, of some forms of non-
syndromic, autosomal dominant, sensorineural hearing impairment. We describe various 
phenotypic features in DFNA2/K'C/VQ4~DFNA9/COCH (Chapter 2), DFNA5/DFNA5 (Chapter 
3), DFNA10/EV/« (Chapter 4) and DFNA13/COZ.Î 1A2 (Chapter5) families. All are the result of 
so-called "concerted actions", either with the Otogenetic Group of the University of Iowa (Prof 
Dr RJH Smith), or with the Department of Medical Genetics of the University of Antwerp (Prof 
Dr G Van Camp), or with the Department of Otolaryngology of Utrecht (Prof Dr EH Huizing). 
At the beginning of this project (October 1999), 31 loci for autosomal dominant non-
syndromic sensorineural hearing impairment had been mapped, and 11 of the relevant 
genes had been isolated. At present, these numbers have been raised respectively to 39 
and 14 (Table 3), and are expected to keep going up. To aid the search for new loci and 
genes, clinical data and blood samples were collected in several large, multi-affected families 
with non-syndromic, autosomal dominant inherited hearing impairment. These DFNA-famihes 
were clinically studied, but are currently undergoing or awaiting genetic analysis at the 
Nijmegen Otogenetic Laboratory. These analyses are likely to yield some new genotypes. 
Nowadays, phenotypic descriptions of unlinked families are no longer regarded as meeting 
the standards necessary for publication. For this reason, this PhD thesis comprises the 
accurate clinical description of other DFNA-famihes that have been previously linked and 
sometimes even undergone mutation analysis. An exception was the Dutch family (Chapter 
2.2) referred for genetic linkage to the Department of Medical Genetics of the University of 
Antwerp (Prof Dr G Van Camp). Since the phenotype in this family resembled previously 
reported phenotypes of known DFUA2/KCNQ4 families, linkage with the DFNA2 locus was 
successfully verified, after which mutation analysis of the KCNQ4 gene was, again with 
success performed.158 
In all families, phenotypic aspects were extensively investigated, and in addition to 
studying pure-tone audiograms, attention was paid to complementary features such as the 
results of speech recognition scores. So, apart from outlining the general phenotypic 
features, we also elaborated on the clinical characteristics of families already studied. Finally, 
Chapter 6 gives an overview of the entire project and presents the final conclusions. 
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Figure 1: Schematic overview of loci and isolated genes (boxed) responsible for the most frequent 
forms of syndromic hearing impairment. Abbreviations are listed in Table 1. With permission of PJ 
Coucke. 
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Introduction 
Over 10 families have been linked to the DFNA2 locus.17 This makes it one of the 
most frequently encountered loci implemented in autosomal dominant non-syndromic 
hearing impairment. The DFNA2 region is located on chromosome 1p34 and has been 
shown to include GJB3 and KC/VCX1'4 GJB3 or connexin 31 encodes a gap junction,3 
whereas KCNQ4 is responsible for the production of KCNQ4 subunits, tetrameres of which 
constitute a voltage-gated potassium channel.4 Both genes are believed to be involved in the 
K+ recycling pathway of the inner ear.5 Most families harbor a mutation in the KCNQ4 gene4'8 
and, interestingly, there is still one family without any detectable mutation, suggesting a third, 
as yet unidentified, DFNA2-linked gene.9 Cochlear expression studies in rat demonstrated a 
basal to apical increasing kcnq4 gradient in inner hair cells and the spiral ganglion cells, 
whereas a reciprocal gradient was found in outer hair cells 10 
We briefly describe previously reported phenotypic data of all DFNA2 families with a 
known mutation.13691115 For the sake of comparison, we statistically analyzed eight of these 
families using similar methods and present typical audiometrie curves for each of them. 
Patients and Methods 
We collected audiograms from mutation carriers of one Belgian, one Japanese, two 
American and four Dutch DFNA2/KCNQ4 families. They all carried a missense mutation, 
except for the Belgian subjects where an inactivating deletion in the KCNQ4 gene was 
involved.6'9 The Japanese, Dutch I and IV family harbor exactly the same mutation (W276S) 
and are probably unrelated.8 W276S is therefore regarded as a potential hotspot for 
mutation. The specific mutations present in each family are shown in Figure 1. Persons 
thought to have other non-hereditary causes of hearing impairment were excluded from the 
analyses. 
Pure-tone hearing thresholds (binaural mean) were analyzed in relation to age (linear 
regression analysis) to construct age-related typical audiograms (ARTA) pertaining to age 
10, 20, 30, 40, 50, 60 and 70 years for the separate families. A previous study on the Dutch 
IV family showed inconsistencies between the cross-sectional and the longitudinal 
analyses.16 It seemed that the former one was unreliable and therefore longitudinal analysis 
was preferred. 
Review and results 
Previously, GJB3 mutations were detected in two small Chinese families.3 They 
demonstrated progressive, high-frequency sensorineural hearing impairment and tinnitus, 
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present from about age 30 years onwards Later, the KCNQ4 gene was cloned and shown to 
be mutated in a small French family with progressive, high-frequency hearing impairment." 
The ARTA of the remaining KCNQ4 families are illustrated in Figure 2. As previously 
described, all families have symmetrical, predominantly high-frequency sensorineural 
hearing impairment, progressive at all frequencies.1 6 9 1 1·1 5 The Belgian family however, has 
a rather atypical phenotype sparing the low frequencies, and more progressively and 
severely affecting the high frequencies. Furthermore, hearing impairment in the USA I family 
seemed to start with higher thresholds in the lower frequencies. In contrast to the other 
families, some of the affected members in the Belgian and both American families reported 
tinnitus.16 All families attained a severe to profound hearing loss by the age of 70. It is likely 
that hearing is congenitally impaired, especially at the high frequencies. Previous reports 
mentioned substantial intrafamihal variation in onset age or offset level, but annual threshold 
deterioration was almost uniformly calculated at approximately 1dB/y. 6 9 1 1 1 5 Most KCNQ4 
mutation carriers required a hearing aid from between 10 and 40 years onwards Vestibular 
testing was described in 37 members of the Dutch I family and 11 members of the Dutch IV 
family and revealed increased vestibulo-ocular reflexactivity in approximately 30% of the 
cases." 14 In addition, speech recognition scores had been analyzed in 45 members of the 
latter Dutch families.1314 Given the level of pure-tone impairment, they presented with 
relatively good scores. Moreover, the scores did not deteriorate substantially before the third 
decade of life and progressed at a relatively low rate. 
Discussion and conclusions 
In general, a certain genotype-phenotype correlation can be recognized in the studied 
DFNA2/KCNQ4 families. The Belgian family with its purely high-frequency loss represents 
one exception. Their deviant phenotype could be the result of their specific type of mutation 
(inactivating), which is probably responsible for a reduced quantity (50%) of normal KCNQ4 
channels (haploinsufficiency). In contrast, all other known mutations lead to a (stronger) 
dominant negative effect with the formation of some normal (1/16) and a large majority of 
dysfunctional channels.9 Further research is necessary to confirm this theory and thus 
confirm the existence of a true phenotype-genotype correlation. 
In conclusion, DFNA2/KCN04-re\aied hearing impairment involves symmetrical, high-
frequency hearing impairment, progressive for all frequencies and probably starting from an 
early age onwards. 
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Figure 1. Graphical representation of the KCNQ4 voltage gated K+ channel. The six transmembrane 
domains (S1-S6) as well as the pore region are indicated. The specific mutations of all families 
represented in Figure 2 are marked. 
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Abstract 
We analyzed hearing thresholds, speech recognition scores and vestibular responses in 32 
affected persons in a large family with 0ΡΝΑ2/ΚΌΛ/04-Γβΐ3ίβα hearing impairment caused by 
a W276S missense mutation. Linear regression analysis of individual longitudinal data 
revealed significant threshold progression (1 dB/year) and offset (at age = 0). Mean offset 
thresholds were 5, 21, 40, 39, 31 and 51 dB HL at 0.25, 0.5, 1, 2, 4 and 8 kHz, respectively. 
Cross-sectional analysis of last-visit thresholds against age produced less steep slopes and 
higher offset thresholds. Nonlinear regression analysis of last-visit phoneme recognition 
scores against age in 25 cases showed that speech recognition did not deteriorate before the 
third decade. A hyperactive vestibulo-ocular reflex was found in 3 out of 11 cases; two were 
especially susceptible to motion sickness. Persons with this KCNQ4 mutation showed 
congenital, progressive, high-frequency hearing impairment without substantial loss of 
speech recognition during the first decades of life. 
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Introduction 
In 1994 a second locus for non-syndromic autosomal dominant sensorineural hearing 
impairment, DFNA2, was identified in an Indonesian and an American family.1 Since then, 
already 10 families have been studied with progressive high-frequency sensorineural hearing 
impairment linked to the DFNA2 region on chromosome 1p34.26 This probably reflects the 
important role of this locus in autosomal dominant inherited hearing impairment.2 
Furthermore, several different genes appear to occupy the DFNA2 region. The connexm 31 
gene (GJB3) was the first to be identified 3 The second was KCNQ4, which encodes a 
voltage-gated K+ channel that is preferentially expressed in the outer hair cells of the 
cochlea." Mutations in KCN04 have been found in 7 unrelated families originating from 
Belgium, France, the Netherlands and the USA. Most mutations caused changes in the P-
loop domain (pore region) of the expressed protein. In contrast with the Indonesian family 
linked to DFNA2,7 all the families that were sufficiently outlined, had fairly similar 
phenotypes.89 Both GJB3 and KCNQ4 may play a role in the K+ recycling pathway of the 
inner ear.9 It is probable that a third, as yet unidentified, DFNA2 gene exists, because the 
affected members of the Indonesian family did not show GJB3 or KCNG4 mutations.7 The 
involvement of 3 different genes is intriguing, but not exceptional given the extreme 
heterogeneity of non-syndromic hereditary hearing impairment. An up-to-date review of all 
genetic information can be found on the Hereditary Hearing Loss Homepage.10 The 
progressive type of high-frequency impairment in DFNA2 resembles presbyacusis. It has 
therefore been suggested that studying this type of hearing impairment may provide more 
insight into the pathophysiology of presbyacusis.2 
Preliminary phenotypic analysis of the present family suggested linkage to the DFNA2 
region, and subsequent genetic analysis revealed a missense mutation in the KCNQ4 
gene.11 In this study we present a detailed audiometrie and vestibular analysis of this fourth 
Dutch DFNA2 family. 
Patients and Methods 
A five-generation pedigree was constructed with the aid of a family member (Figure 
1). Eighty-six members of the family participated in this study after giving informed consent. 
They, or their parents if they were too young, were asked to fill out a questionnaire to exclude 
other causes of hearing impairment. Special attention was paid to features of syndromic 
hearing impairment. All the participants underwent otoscopie and audiometrie examination 
and donated a blood sample Pure-tone and speech audiometry were performed in a sound 
treated room according to current clinical standards. Tympanograms were only evaluated in 
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incidental cases (glue ears). Computerized tomography of the temporal bones and brainstem 
auditory evoked potentials were performed in one affected person. 
Figure Τ Family pedigree. Circles, women; squares, men. Filled symbols denote hearing impairment 
Numbered persons participated in the study. Mutation carriers are labeled with an asterisk. Italics near 
descendant lines specify numbers of individuals 
The present analyses were only performed on the patients for whom mutation 
analysis of the KCNQ4 gene disclosed a W276S mutation." 
We used the average audiogram slope over 5 octaves (from 0.25 to 8 kHz) to classify 
audiogram configuration, according to the following specifications: flat (slope < 5 dB/octave), 
gently sloping (5 dB/octave < slope < 10 dB/octave) and steeply sloping (slope > 10 
dB/octave). 
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Longitudinal analyses included previously obtained audiograms. Using a commercial 
program (Prism, version 3.0, GraphPad, San Diego, CA, USA), linear regression analysis 
was performed to evaluate progression in hearing impairment (pure-tone thresholds) and to 
extrapolate the offset threshold (i.e. the threshold at age zero). Out-of-scale measurements 
were excluded from the analyses. It was tested whether the correlation coefficient was 
significant, which implied that the regression coefficient, i.e. slope - here called annual 
threshold deterioration (ATD, in dB/year) - differed significantly from zero. The Prism 
program's F test option (analysis of variance, ANOVA) was used to determine which 
regression lines could be pooled The program first tested between slopes and it only tested 
between intercepts if the slopes were not significantly different at the P=0.05 level. In each 
affected person, progression was considered to be significant if a significantly high number of 
frequencies out of the frequencies measured, showed significant progression. Relative 
frequencies were labeled as significant if they were related to a tail probability of Ρ < 0.05 in 
the appropriate binomial distribution (n = 6 for 6 frequencies, ρ = 0.025 for a significant 
positive correlation coefficient). The Y intercept - or offset (threshold) - was derived by 
extrapolation and subjected to similar statistical tests as the slope. For lines with a negative 
Y intercept, it was tested whether the positive X intercept (onset age) differed significantly 
from zero by calculating 95% confidence limits for the latter intercept by performing a 
nonlinear fit using the equivalent equation Y = Slope.(X - Xmtercepi)· 
Cross-sectional analysis, comprising linear regression analysis, was also performed 
for the purpose of comparison, using only the last-visit threshold data 
Speech audiometry (n=25) involved evaluating speech reception threshold and the 
maximum recognition score (in a performance-intensity plot) for phonemes using standard, 
phonetically balanced Dutch word lists. Cross-sectional analysis was performed on the most 
recent scores with simultaneous measurement of sufficient pure-tone thresholds (including 1, 
2 and 4 kHz). The recognition scores for the right ear were fitted with a sigmoidal dose-
response equation with variable slope against age, as well as the pure tone average (for the 
right ear) for 1, 2 and 4 kHz (PTAi 24 KHZ) using a logarithmic scale for the X variable. These 
plots were compared to similar plots obtained previously at our clinic in a group of 45 patients 
with presbyacusis alone (author's unpublished data). 
Vestibular examination was performed on 11 mutation carriers. Vestibular testing 
comprised rotatory and caloric stimulation with the patient in the dark (eyes open) and 
electronystagmography, including computer analysis, as previously described.12'15 
Response parameter values were labeled as significant at the 5% level. The group 
prevalence of significant findings was related to the corresponding binomial distribution (as 
already described above) to see whether it was significant (P = 0.05). 
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Results 
We analyzed 33 clinically affected persons with a W276S mutation in KCNQ4 gene 
(labeled with an asterisk in Figure 1). One of them (Case 50) also had osteogenesis 
imperfecta and was therefore excluded from further analyses. Hearing impairment was also 
present in some non-carriers of the mutation (Cases 1, 4, 24, 31, 40 and 41). Case 1 had 
developed high-frequency hearing impairment already in the second decade. Case 4 was 
related by marriage. Case 24 had a history of meningitis. Case 31 was the son of two 
hearing impaired parents (Cases 3 and 4). Cases 40 and 41 showed atypical audiograms. 
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Non-numbered persons did not participate in this study; some of them were affected by 
history. 
Figure 2 shows the pure-tone audiograms of the mutation carriers. As all the cases 
showed fairly symmetrical audiograms, only the right ear was included (the left ear in Case 
81 because the right ear was not measured). Audiogram configuration was classified as 
gently sloping in 13 cases, steeply sloping in 16 cases and flat in 3 cases. A flat configuration 
was found only at age < 6 years (Figure 2: Cases 71, 82 and 84). In Case 48, the 
configuration was gently sloping at age 5-12 years and steeply sloping at age > 38 years. 
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Figure 3' Longitudinal analyses at separate frequencies in 10 mutation carriers Consecutive air 
conduction thresholds (right ear, dB HL) are plotted (circles connected with hair lines) against the 
patient's age (y = years) Individual regression lines are included, a bold line indicates significant 
progression The dotted line is a trend line with a slope (ATD) of 1 dB/year (ι e the pooled slope of the 
separate regression lines) The intercept of this line (bold figure near Y axis) was calculated as the 
weighted mean of the individual intercepts The two individual regression lines with the most extreme 
slopes (small circles) were excluded from this calculation The dashed line in each panel is the 
regression line obtained in the separate cross-sectional analysis 
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Figure 3 shows the longitudinal analyses (right ear threshold against age). Only cases 
with more than 3 measurements that covered a suitable age range were included. Significant 
progression (bold lines) was found at a significantly high number of frequencies in 6 out of 
the 10 persons that could be evaluated This indicates a significantly high prevalence (i.e. Ρ 
< 0.05 in a binomial distribution with ρ = 0.025 and η = 10), which provides evidence for 
systematic progression. In most cases, the slopes (ATDs) could be pooled for most of the 
frequencies (data not shown). These values were also used to obtain across-subject 
estimates of the ATD. The resulting values at 0.25-8 kHz were in the range of 0.8-1.4 
dB/year and could be pooled (ATD = 0.99 dB/y) after excluding 6 (out of the 50) lines with 
extreme slopes. For each frequency, the weighted, across-subject mean offset threshold (Y 
intercept) was calculated using a weight of 1/SE. All frequencies showed significant 
prevalence (from 2 out of 4 cases to 6 out of 10) of significant (> 0) offset thresholds. Only 3 
lines (out of 50) related to a significant onset age: the values were 9, 19 and 24 y. A 
significant majority of the findings thus showed congenital hearing impairment at all 
frequencies. 
Cross-sectional analysis using the last-visit thresholds of all cases produced a pooled 
ATD value of 0.6 dB/year (across-frequency range 0.48-0.96 dB/y) and offset thresholds of 
16, 30, 41, 48, 53 and 63 dB at the increasing frequencies (dashed lines in Figure 3; it should 
be realized that not all cross-sectional data are shown). The ATD values were thus 
substantially lower and the offset values were higher than the values pertaining to the 
(dotted) trend lines in the individual longitudinal analyses. 
The speech reception threshold (data not shown) was generally in agreement with the 
pure-tone audiogram. Cross-sectional analyses of the phoneme recognition scores are 
shown in Figure 4. Panel A shows the deterioration in speech recognition scores with 
increasing age in the DFNA2 (circles) and presbyacusis patients (crosses). In the DFNA2 
patients, speech recognition did not deteriorate substantially before the third or fourth decade 
(a 90% score was reached at age 36 years; 95% confidence range 26-49 years). Figure 4B 
shows that speech recognition in the DFNA2 patients deteriorated substantially only after a 
relatively high level of pure-tone hearing impairment had developed. The 90% score was 
reached at about 66 dB (95% confidence range 56-76 y). The DFNA2 patients showed 
earlier and slower deterioration of speech recognition than the presbyacusis patients (Figure 
4A). At similar PTAi24 KHZ levels, the DFNA2 patients tended to have somewhat higher 
scores than the presbyacusis patients (Figure 4B). There was only a minor difference in 
slope between the two fitted curves. 
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Figure 4 (A, B): Cross-sectional analysis of binaural mean phoneme recognition scores (%) against 
(A) age (y = years) and (B) PTA, 2 4 kHz in 25 mutation carriers (circles and bold line) and 45 
presbyacusis patients (crosses and thin line) The sigmoidei curves were fitted with a nonlinear 
equation. 
Vestibular examination was performed in 11 affected persons. We found a significant 
prevalence of vestibular hyperreactivity (3 out of 11 cases). Two of the persons with 
hyperactive responses were especially susceptible to motion sickness, while none of the 
other affected persons reported such susceptibility or balance problems. Two persons 
showed hypoactive rotatory responses (not significant), but normal caloric responses. 
Computerized tomography showed a normal temporal bone configuration in Case 43. 
Brainstem auditory evoked potentials in this patient were also normal. 
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Discussion 
The KCNQ4 W276S mutation has hitherto been found to be the causative agent of 
hearing impairment in 3 families, two of Dutch and one of Japanese origin.711 Haplotype 
analyses argued against a common ancestor of the Japanese and the two Dutch families." 
Position 276 in the KCNQ4 gene is therefore a potential hotspot for mutation, leading to 
progressive high-frequency hearing impairment. 
In this study, we performed longitudinal analyses (Figure 3) as well as cross-sectional 
analysis (dashed regression lines in Figure 3) in this second Dutch family with the KCNQ4 
W276S mutation. Comparison of the results obtained with the two methods revealed a 
discrepancy that compromised the reliability of the cross-sectional analysis. A possible 
explanation can be sought in the large intersubject differences in offset level and/or onset 
age. Given the lack of sufficient longitudinal data in our previous DFNA2 studies, the 
possibility of similar bias in those cross-sectional data cannot be excluded. The sparse 
longitudinal data (data not shown) in previously reported DFNA2/K'C/\/04 families1618 did not 
differ substantially from the present data. As previously suggested, the higher ATD values in 
the longitudinal analyses may be related to the tendency for cases with more severe 
progression to undergo serial measurements. In the present family, suitable longitudinal data 
(n > 3) were available in 10 cases (Figure 3). We also inspected the data of all the other 
cases (n = 22) and found no indications that these were substantially different from the 
available longitudinal data. Therefore, the suggested mechanism of (self)selection does not 
seem to apply to the present family. 
In this family, there was a tendency for excessively high thresholds to occur at a very 
young age (Figure 2). This finding can be questioned Threshold measurement at a young 
age can be very difficult. The flat audiometrie configuration seen only at a very young age 
may (also) have been caused by unreliable measurements. 
Similar to our previous studies on Dutch families with KCNQ4 mutations,16'9 we did 
not find any indications of substantial nonlinearity of progression in hearing impairment, but 
the longitudinal nature of the present study lends more credibility to this contention. The 
present analyses clearly indicated steady, approximately parallel, progression at all 
frequencies by an average of 1 dB/y (=ATD, see Figure 3). 
In all our previous reports on DFNA2-linked families,1619 we mentioned the possibility 
of prelmgual hearing impairment at the higher frequencies, but this could not be sufficiently 
substantiated with longitudinal data analyses. Some firm conclusions can be drawn from the 
present results. The statistical tests performed in individual cases clearly indicated that 
substantial hearing impairment (most prominent at the higher frequencies and amounting to 
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50 dB) was present already at a very young age and was most probably congenital. With an 
ATD of 1 dB/year, such individuals will develop a total loss of about 50 + 60 = 110 dB by the 
age of 60 years. Recent experimental studies420 have shown predominant cochlear 
expression of KCNQ4 in the outer hair cells (OHCs). Loss of OHC function can cause a 
maximum of 60 dB hearing loss.21 It can be suggested that congenital failure in OHC function 
accounts for the observed (strictly speaking, derived) congenital threshold elevation. Further 
progression in hearing impairment may be explained in terms of secondary effects of the loss 
of OHC function. Failing K+ efflux through the basolateral membrane might not only lead to 
poisoning of these cells,20 but also to collateral damage. Failing recycling of K+ ions back to 
the endolymph might lead to failure in endolymph ion homeostasis and jeopardize the 
function of important structures, such as inner hair cells and afferent cochlear neurons. 
Marres et al.19 reported that a substantial proportion of the patients (25 to 35%) with a 
W276S mutation in the KCNQ4 gene showed vestibular hyperactivity in response to rotatory 
stimulation. Some of these patients were especially susceptible to motion sickness. None of 
the other patients had any relevant vestibular signs or symptoms That was the only previous 
study on DFNA2 which included vestibular testing. Fairly similar observations were made in 
the present family. Kharkovets et al.20 have recently found that kcnq4 in mice is also 
expressed abundantly in type I vestibular hair cells, as well as in afferent vestibular neurons 
and their terminals in the vestibular nuclei. It therefore seems possible that our finding of 
vestibular hyperactivity in the two families with the W276S mutation can be explained on the 
basis of release from (central) inhibition. 
This is the first report on DFNA2/KCNQ4 that addressed both pure-tone thresholds 
and speech recognition. Our cross-sectional analysis indicated that, although hearing 
impairment was present prelmgually, especially at the higher frequencies, postlingual 
progression had the most substantial influence on speech recognition (Figure 4A). Not 
unexpectedly, DFNA2 patients showed an earlier decrease in speech recognition scores 
than presbyacusis patients (Figure 4A). It should be noted that our presbyacusis data may 
have been biased by (unavoidable) selection of patients with speech recognition problems. 
So, the higher rate of deterioration in the presbyacusis patients may reflect bias of case 
selection. This also applies to the observation that the DFNA2 group had better recognition 
scores at similar threshold levels (Figure 4B). It would seem that the relatively good 
recognition scores in our DFNA2 patients were not associated with substantial involvement 
of central auditory pathways. Such involvement has recently been suggested in the mouse 
on the basis of expression studies.20 Furthermore, we could not detect any abnormalities in 
brainstem auditory evoked potentials in one of the affected family members. Additional 
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auditory tests on retrocochlear function should be performed in suitable cases to help clarify 
this issue in relation to DFNA2/KCNQ4 patients 
Addendum 
Recent re-examination and more extensive analysis of murine KCNQ4 expression in the inner ear 
showed that it is expressed in both inner and outer hair cells There are longitudinal gradients along 
the cochlear duct involving most abundant expression in inner hair cells at the base of the cochlea and 
in outer hair cells at the apex (Beisel KW, Nelson NC, Delimont DC et al Longitudinal gradients of 
KCNQ4 expression in spiral ganglion and cochlear hair cells correlate with progressive hearing loss in 
DFNA2 Mol Brain Res 2000, 82 137-149) 
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Abstract 
Objective: To analyze the relationship between pure-tone hearing threshold and speech 
recognition performance in DFNA2/K,C/\/04 and DFNA9/COCH, two types of high-frequency 
non-syndromic hearing impairment. 
Design: Case series study with cross-sectional analysis of phoneme recognition scores, as 
related to age and hearing level. 
Setting: University hospital department. 
Patients: 45 members of 4 separate families, all carrying one of three different mutations in 
the KCNQ4 gene at the DFNA2 locus (1p34); 42 members of 7 separate families, all carrying 
the same Pro51Ser mutation in the COCHgene at the DFNA9 locus (14q12-q13). 
Results: The deterioration of speech recognition dropped to a 90% score at a higher level of 
hearing impairment (PTA,
 2 4 KHZ) m DFNA2 patients (65 dB) than in DFNA9 patients (46 dB). 
Conclusion: At similar levels of hearing impairment DFNA2/KCN04 patients showed better 
speech recognition performance than DFNA9/COCH patients. 
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Introduction 
Autosomal dominant non-syndromic types of hereditary sensorineural hearing 
impairment can be identified by genetic linkage and mutation analysis. The corresponding 
chromosomal loci are genetically designated DFNA, followed by a number in order of 
discovery (DFN = deafness, A = autosomal dominant inheritance).1 One locus may harbor 
one or more disease-causing genes. The discovery of such genes and their function may 
enhance our understanding of the pathophysiology of the inner ear. At the same time, clinical 
studies are necessary to relate the latter to the resulting phenotype. 
Clinical studies on DFNA2/K'C/V04 and DFNA9/COCH families have demonstrated 
fairly similar high-frequency sensorineural hearing impairment and progression (authors' 
unpublished data).2 's In addition to hearing loss, DFNA9 patients also develop vestibular 
failure.6"131516 The DFNA9 families studied in the Netherlands and Flanders all have the 
same mutation in the COCH gene, corresponding to a P51S substitution in the expressed 
protein, cochlm.121718 The function of cochlm is still unknown. In the four Dutch DFNA2 
families, three different mutations (W276S, G321S, L274W) of the KCNQ4 gene were 
found 1920 KCNQ4 encodes a potassium channel that is predominantly expressed in the 
basolateral membrane of cochlear hair cells.2122 
The present study focuses on the relationship between speech recognition 
performance on the one hand and age and pure-tone hearing threshold on the other hand in 
two different types of non-syndromic, autosomal dominant, sensorineural hearing 
impairment. The two, DFNA2/KCNQ4 and DFNA9/COCH, are both characterized by 
progressive, predominantly high frequency hearing impairment. 
Patients and methods 
This study compared speech recognition data between DFNA2/KCNQ4 and 
DFNA9/COCH patients. 
The group of DFNA2 patients comprised speech recognition data obtained from 45 
carriers of a mutation in the KCNQ4 gene. There were 30 patients from two families with a 
W276S mutation (authors' unpublished data),251910 patients with a G321S mutation319 and 
5 patients with a L274W mutation.420 
The group of DFNA9 patients comprised speech recognition data obtained from 42 
carriers of the P51S mutation in the COCH gene, from 6 Dutch6'11131718 families and 1 
Flemish family (authors' unpublished data).17 
Audiometry was performed according to common clinical standards. For speech 
recognition, standard monosyllabic Dutch word lists were presented at either ear.23 
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Performance-intensity curves relating to the phoneme recognition score were analyzed for 
the right ear only The last-visit speech reception threshold (SRT, in dB SPL for 50% 
phoneme score) and the maximum phoneme recognition score (%Correct), at which the 
pure-tone-threshold at 1, 2 and 4 kHz could be measured, were used 
Plots of SRT versus PTAi 2 A KHZ (Pure-Tone-Average at 1, 2 and 4kHz) were used with 
linear regression analysis to check for the reliability of the phoneme recognition scores 
Chauvenet's criterion2 4 and the residual standard deviation (SD) were used to identify and 
exclude outlying values 
Because a comparison of speech recognition scores between the patient groups may 
be complicated by underlying differences in hearing threshold, the thresholds at each 
frequency for "modal-age" patients between the groups were compared, using Student's t 
test These patients were selected from each group by requiring their age to be within the 
limits of the percentiles P375 and P625 of the corresponding age distribution 
Nonlinear regression analysis of the maximum phoneme recognition score on 
log(age) and on log(PTA1 24 KHZ) was performed using the Prism PC version 3 02 program 
(GraphPad, San Diego CA, USA) Cross-sectional and individual longitudinal performance-
age (%Recognition versus age) and performance-impairment plots (%Recognition versus 
PTA, 2 4kHz) were fitted with a sigmoidal dose-response function with a variable slope1 3 
Y = 100% / (1 + 10<l09X9o l 0 9 X ) H" l s l o p e l 0 9 9 ) , where Y is phoneme score, X is either age or 
PTA, 24 KHZ, X90 is the value of X where Y = 90%, and HillSlope is the slope factor on a log 
scale of X The fitted values of X90 and HillSlope were used to test between curves relating to 
the patient groups, using Student's t test (with Welch's correction if Bartlett's test detected 
unequal variances) 
To simplify the results and allow for additional testing, "local average" slope (ι e on a 
linear scale) for X > X90 was obtained by using a linear regression line as an approximation of 
the corresponding part of the fitted sigmoidal curve Slope was called deterioration rate in the 
performance-age plot, whereas it was called deterioration gradient in the performance-
impairment plot X90 was called onsef age for the performance-age plot and onsef level for 
the performance-impairment plot Regression lines were compared between the groups 
using analysis of covanance (ANCOVA) to find out whether slopes and intercepts were 
significantly different Again, Chauvenet's criterion was used in combination with the residual 
SD to detect outlying values 
Individual longitudinal data were available in 18 DFNA2/K'C/\/04 and 23 
DFNA9/COC/-/ patients Analyses comprised plotting of serial phoneme recognition scores 
against age and PTA, 2 4 kHz, and comparing these to the curves fitted to the corresponding 
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cross-sectional data. A 5% lower normal limit established at the Nijmegen ENT department 
(authors' unpublished data) was used to see whether there were scores that raised suspicion 
of retrocochlear dysfunction. 
The phenotype of the ΟΡΝΑ2/ΚΌΛ/04 patients may be influenced by the nature of the 
mutation that is present in the family. In addition, even for patients carrying the same 
mutation, differences in other genes (genetic background) may also influence the phenotype. 
It was therefore checked whether there were significant differences in score behavior 
between either the different DFNA2//<'C/\/04 and the different DFNA9/COC/-/families 
Results 
In each group, the SRT showed an excellent correlation with the corresponding 
PTA, 24 kHz (n = 33 - 44 after exclusion of 3 outlying values; r = 0.8-0.9, residual SD = 9-13 
dB). This corresponds fairly well with the residual SD found by Bosman et al.23 
Mean pure-tone thresholds for a representative, "modal-age" selection from each 
group, i.e cases with P375 < age <P62 5 (percentiles in the frequency distribution of age), 
generally did not differ significantly at any frequency. 
Figure 1 shows cross-sectional performance versus age plots (panels A and B) and 
combined performance-impairment plots (panel C). Onset age was 34 years in 
DFNA2/KCNQ4 and 43 years in DFNA9/COC/-/ patients. The local average deterioration rate 
in DFNA2 patients was 0.3 %/year, whilst in DFNA9 patients it was 1.8%/year (Figure 1A, B). 
There was no significant difference in HillSlope between the plotted curves in panel C. 
However, the local average deterioration gradients were significantly different (0.5%/dB 
versus 1.2%/dB). The latter finding is related to the significant difference in onset level that 
can be detected (65 versus 46 dB), as well as the observation that there is clear separation 
between the datapomts (Figure 1C). In other words· at a given level of impairment, 
DFNA2/KCNQ4 patients showed higher scores than DFNA9/COCH patients 
Individual longitudinal analyses produced fairly similar results to the cross-sectional 
analysis (data not shown) Four of the DFNA9/COCH patients showed scores below the 
normal limit which would have raised a suspicion of retrocochlear dysfunction. Some of these 
scores renormalized during follow-up. None of the DFNA2/KCNQ4 patients showed any 
scores suspect for retrocochlear dysfunction. 
No significant differences in score behavior between either the different 
DFNA2/KCNQ4 families or the different DFNA9/COCHfamilies were found (data not shown). 
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Figure 1 (Α-C) Speech recognition score against age (y = year, panels A and B) and pure tone 
average (PTA) at 1,2 and 4 kHz (panel C) in DFNA2JKCN04 (circles) and DFNA9/COCH (triangles) 
Small symbols indicate outlying values 
Discussion 
The marked difference in speech recognition performance as related to hearing level 
between DFNA2//<C/V04 and DFNA9/COCH, both characterized by predominantly high-
frequency sensorineural hearing impairment, is an appealing finding in this study 
Better recognition scores in the DFNA2 patients are remarkable, especially in light of 
recent findings that the mouse homologue of KCNQ4 is abundantly expressed in the central 
auditory pathways 25 KCNQ4 is thought to play a role in the K* recycling pathway of the inner 
ear 2 1 2 6 Three of the four studied families with DFNA2/K'C/V04 patients had different 
mutations, but fairly similar speech recognition The L274W and W276S mutations produce 
changes in the pore region of the expressed K+ channel protein, whereas the G321S 
mutation exerts an effect just outside the pore region, however, apparently to a similar 
phenotypic effect20 
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On the other hand, the DFNA9/COCH patients had poorer speech recognition scores, 
as compared to age and hearing level (Figure 1C). The American COCH patients, with a 
V66G mutation,2728however, showed an even greater drop in recognition scores.14 The latter 
had earlier onset (at age 20 year) and anacusis at around age 45 y. Combined speech 
performance-impairment plots of the recognition scores (not shown) are suggestive of 
relatively poorer scores in the American V66G carriers. However, our longitudinal analyses 
also disclosed the existence of temporarily poor scores in some of our DFNA9/COCH 
patients. Such poor scores may have been related to Ménière-like paroxysms." 12 
Histopathologic findings reported for one American COC/-//V66G mutation carrier 
comprised general destruction of the cochlear and vestibular sensory elements, including 
hair cells and dendrites (cochlea, crista and macula), as well as accumulation of an acellular 
substance (glycosaminoglycan) throughout the labyrinth.15 These findings were similar to 
those reported previously in COCH patients.1629 In chicken, COCH expression was found in 
fairly similar places where the deposits were found in human patients.28 It has been 
postulated that "strangulation" of cochlear and vestibular nerve endings occurs.152829 
Alternatively, the possibility was suggested that normal fibnllogenesis is disrupted by an 
excess in microfibrillar substance, which results in degradation of collagens and extracellular 
matrix components.15 It is also possible that cochlm, which is expressed in the stroma 
underlying the sensory structures of the inner ear,28 has a role in ion homeostasis, for example, 
recycling of K+ ions from the hair cells to the endolymph.12 
In the present study, OFNIK2.IKCNQ4 patients appeared to have better speech 
recognition scores than DFNA9/COCH patients (Figure 1 C); the difference could not be 
explained by underlying differences in pure-tone thresholds. Cochlear KCN04 expression 
was initially thought to be confined to the outer hair cells.21 However, recent findings in the rat 
have shown that it is also expressed in inner hair cells and the spiral ganglion.22 The 
strongest KCNQ4 expression, i.e. in normally hearing animals, was found in inner hair cells 
in the lower cochlear turns and in outer hair cells in the upper turns. Thus DFNA2/KCNQ4-
related high-frequency sensorineural hearing impairment, which is associated with primary 
dysfunction of the lower cochlear turns, might be attributed to a lack of expression of K+ 
channels, especially in inner hair cells. Relative sparing of function of outer hair cells in the 
lower turns, thus preserving their function as "cochlear preamplifier" in finetunmg 
mechanisms,30 might account for the better speech recognition m DFNA2/KCNQ4 patients. 
On the other hand, the poor recognition scores m DFNA9/COC/-/ patients might be explained 
by the generalized, histopathologic, vestibulocochlear changes,15162829 already mentioned 
above, and, in part, by its Ménièriform features.1112 
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Chapter 3.1 
Chapter 3 1 
Introduction 
So far, only one DFNA5 family has been found It is a Dutch family, and one of the 
largest families with non-syndromic inherited hearing impairment ever reported The family 
consists of 6 branches, 3 of which contain affected persons One of these "affected" 
branches is shown in Figure 1 The first clinical descriptions date from the late sixties13 and 
the family has been followed ever since,48 but it took until 1995 to link the trait to 
chromosome 7p159 Following refinement of the DFNA5 candidate region,10 the mutated 
gene was identified " It involves a complex insertion/ deletion mutation which results in 
premature truncation of the expressed protein The gene was called DFNA5 as its function 
remains to be clarified 
We review the previous reports on this family19 and present its typical audio-
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Figure 1 Branch 6 of the DFNA5family Filled symbols indicate hearing impairment 
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Patients and Methods 
In contrast to previous studies on DFNA5, we only analyzed audiograms of proven 
mutation carriers (n=106). Some affected members were excluded because of the presence 
of additional non-hereditary factors. Audiograms were recorded with a portable or clinical 
audiometer according to common standards. As hearing loss appeared to be symmetrical, 
we only used right ear threshold data. Pure-tone hearing thresholds (last visit) were analyzed 
in relation to age (linear and non-linear regression analyses) to construct age-related typical 
audiograms (ARTA) at 10, 20, 30, 40, 50, 60 and 70 years. Initial progression was assessed 
with a graphical method (slope tangent fitted by eye) to obtain the maximum ATD (Annual 
Threshold Deterioration) for each frequency. We also tested whether it was possible to pool 
parameter values for different frequencies. 
No records of vestibular testing have been reported previously. Recently we 
performed vestibular examination in 4 affected members of one branch of the family aged 
12-65 years. Vestibular testing comprised rotatory and caloric stimulation with the patient in 
the dark (eyes open) and electronystagmography, including computer analysis.1215 
Response parameter values were labeled significant at the 5% level. 
One affected person underwent computerized tomography of the temporal bones. 
Review and Results 
By way of illustration, we present the individual last-visit audiograms of affected 
members of the second branch of this family in Figure 2. Previous studies1'7 already 
demonstrated a variety of audiogram types. Most audiogram configurations were classified 
as a so-called Z-shape curve. It is characterized by (sub)normal hearing up to about 1 kHz, a 
large drop between 1 and 2 kHz and a flat loss of about 80 dB above 2 kHz. In addition, 
progression was examined and despite great variance in the rate of deterioration between 
the individual cases, a clear pattern could be recognized. First of all, progression was most 
pronounced in the first three decades of life, and secondly, the low frequencies deteriorated 
at a much lower rate than the high frequencies. Figure 3 illustrates the different phases of 
deterioration.6 Age of onset was determined between 5 and 15 years in the majority of 
patients. 
The present analyses provide a more general picture of the family, but the different 
stages can still be recognized. ARTA (Figure 4) show a configuration that evolves from flat (at 
10 y) through gently-sloping (at 20 y) into steeply-sloping (at 30-70 y). Again, the high 
frequencies were shown to be more severely and more rapidly affected, particularly in the 
first decades. We calculated a pooled ATD of about 1 dB/y for 0.25 to 1 kHz, and a maximum 
ATD of approximately 1 -4 dB/y at frequencies increasing from 2 to 8 kHz. 
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Figure S Stages (1-6) of hearing deterioration with corresponding configuration 
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Speech recognition scores had been analyzed in 34 carriers and given the rapid 
progression in hearing impairment, speech recognition was relatively good: at age 70, the 
score was still >50%.16 
None of the family members had any vestibular symptoms, nor complaints of tinnitus. 
The response parameter values of the 4 tested patients were normal with few exceptions. 
None of the relative frequencies of these abnormal values was beyond chance level 
(binomial distribution statistics). 
Computerized tomography showed a normal temporal bone configuration. 
Conclusions 
DFNA5 shows rapid initial progression (1-4 dB per year) at 2-8 kHz in the first 
decades, which slows down at a more advanced age, and steady progression (1 dB per 
year) at 0.25-1 kHz. 
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Abstract 
Speech recognition scores were analyzed in 34 carriers of a DFNA5 mutation. Cross-
sectional linear regression analysis (last visit, maximum recognition score in %Correct on 
age or PTAi 2 4 KHZ) established onset age (score 90%) at 16 years and onset PTA12 4 kHz level 
(score 90%) at 41 dB HL. The deterioration rate was 0.7%/year in the maximum score 
against age plot, whereas the deterioration gradient was 0.4%/dB in the maximum score 
against PTA,24
 kHz plot. Given the previously demonstrated rapid progression in hearing 
impairment, speech recognition was relatively good: at age 70, the score was still > 50%. 
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Introduction 
Sensorineural hearing impairment is one of the most frequent handicaps in the world. 
Since the late 1800s, hereditary factors have been recognized among its causes. Our 
knowledge about inherited sensorineural hearing impairment has expanded tremendously 
owing to the development of genetic linkage techniques. These techniques enable us to 
localize a region within the DNA in which the affected gene is situated. According to the 
mode of inheritance a locus for non-syndromic inherited hearing impairment is called DFNA 
(autosomal dominant), DFNB (autosomal recessive) or DFN (X-linked). The loci are 
numbered in chronological order of discovery. Once a locus has been mapped, the search 
for the causative gene can begin. Currently, almost 80 loci for non-syndromic hearing loss 
have been found, and 21 genes have been identified.1 
In 1966, Huizing et al. described a very large Dutch family with autosomal dominant 
sensorineural hearing impairment.2 At the last follow-up study (1994-1997), the family 
comprised 121 affected members (authors' unpublished data). Several phenotype studies on 
the family have been published, providing a detailed analysis of the segregating trait. 2"θ The 
type of hearing impairment was characterized as postlingual and progressive, the high 
frequencies being most severely affected and showing the highest, especially initial, 
progression. Linkage and genotype analyses were performed in the past few years.9'11 The 
trait was mapped to chromosome 7p15 and given the designation DFNA5.9 After refinement 
of the region, the disease-causing gene was isolated and named DFNA5 because the 
function of the gene (which would suggest a new name) is as yet unknown.1011 Cochlear 
expression of a DFNA5 homologue was found in the mouse." 
To further delineate the phenotypic features we analyzed the speech recognition 
scores in a number of DFNA5 mutation carriers. 
Patients and Methods 
Audiometry was performed using a portable or a clinical audiometer according to 
common clinical standards 2'8 For speech recognition, standard phonetically balanced Dutch 
word lists were presented at either ear. Speech recognition scores (right ear only) were 
retrieved from 34 DFNA5 mutation carriers, aged 7-67 years. Performance-intensity curves 
relating to the phoneme recognition score were analyzed (last visit). We included the speech 
reception threshold (dB SPL at 50% phoneme recognition score) and the maximum 
(unaided) phoneme recognition score (%Correct) at which the pure-tone-average at 1, 2 and 
4 kHz (PTAi 2 4 kHz) could be measured. 
Plots of speech reception threshold versus PTAi 24 KHZ were used with linear 
regression analysis to check for the reliability of the phoneme recognition scores. 
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Chauvenet's criterion12 and the residual standard deviation were employed to identify and 
exclude outlying values. Linear regression analysis of the maximum phoneme recognition 
score on age (performance-age plot) or PTA, 24 mz (performance-impairment plot) was 
performed with the Prism PC version 3.02 program (GraphPad, San Diego CA, USA). X9o, 
i.e. the value of X where / = 90% (called onsef age for the performance-age plot and onsef 
level for the performance-impairment plot) and its 95% confidence interval were derived 
using a nonlinear regression method to fit the equivalent linear equation Y = Slope(X-Xgo) + 
90. Slope was called deterioration rate in the performance-age plot, whereas it was called 
deterioration gradient in the performance-impairment plot. 
Longitudinal recognition scores (n = 2-12) were available and analyzed in 10 cases. 
Results 
The speech reception threshold (data not shown) correlated significantly with the 
PTA, 2 4 kHz level and was generally in agreement with the pure-tone audiogram. The 
maximum phoneme recognition scores are plotted against age in Figure 1A. Speech 
recognition scores deteriorated significantly (slope >0) with increasing age. Onset age was 
16 years (95% confidence interval 10-22 years) and the deterioration rate was 0.7%/year 
(95% confidence interval 0.4-0.9%/year). Figure IB shows an onset level of 41 dB (95% 
confidence interval 30-52 dB) and a deterioration gradient of about 0.4 %/dB (95% 
confidence interval 0.2-0.6%/dB). Figure 1A and Β each include one outlying value (asterisk) 
representing a patient who showed exceptionally rapid progression for the trait. He was 
followed for many years (see Figure 2). Interestingly, this patient received a cochlear implant 
and performed very well since. This patient's score, as well as the scores in the other 
patients, were well above the 5% lower confidence limit for cochlear lesions observed at our 
laboratory (included in Figure 2). 
Longitudinal data are depicted in Figure 2. The patient elected for cochlear 
implantation at age 26 years (n = 12) is easily recognized by a large drop in speech 
recognition scores (Figure 2A, asterisk). However, despite this patient's exceedingly poor 
(unaided) scores the usual relationship between score and PTA, 21 kHz level was maintained. 
Some, but not all, of his scores were lower than our 5% lower normal limit (dotted line). 
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Figure 1 (Α, Β) Cross-sectional speech recognition scores at last visit against age (y = year, panels 
A) and pure tone average (PTA) at 1,2 and 4 kHz (panel B) Asterisks indicate outlying values 
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Figure 2 (A, B) Individual longitudinal speech recognition scores against age (y = year, panels A) and 
pure tone average (PTA) at 1,2 and 4 kHz (panel B) are depicted by circles and continuous lines 
Asterisks pertain to the same patient as in Figure 1 Dotted line indicates 5% lower normal limit for 
cochlear losses established at our laboratory 
Discussion 
The DFNA5 patients showed onset of deterioration of speech recognition in their 
second decade (onset age 16 y) Previously, on the basis of the analysis of pure-tone 
audiograms, van den Wijngaart concluded to an onset age between 5 and 15 y e a r s 8 These 
onset ages are at a much younger age than previously found in patients with other 
progressive, autosomal dominant traits predominantly affecting the high frequencies, such as 
DFNA2/KCNQ4 (34 y) and DFNA9/COCH (43 y ) 1 3 The deterioration rate in our DFNA5 
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patients (0.7%/year) was higher than in our DFNA2 patients (0.3%/year), but much lower 
than in our DFNA9 patients (1.8%/year). It was checked that the threshold levels typical of 
our DFNA5 patients were fairly similar to those in our DFNA2 and DFNA9 patients (data not 
shown). 
The relatively slow deterioration in speech recognition is remarkable in light of the 
rapid progression in hearing loss documented for our DFNA5 patients.2'8 Their extrapolated 
maximum score was still > 50% at about 70 years of age (Figure 1A). A puzzling exception 
was the young man, whose excessive deterioration prompted to cochlear implantation at the 
age of 26 years. The fact that he performed very well following implantation (data not shown) 
supports our assumption, based on a murine cochlear expression study,11 that the DFNA5 
mutation causes purely cochlear dysfunction. 
The onset ΡΤΑί
 24ΚΗΖ level in our DFNA5 patients was about 40 dB HL; this was fairly 
similar to the onset level (about 45 dB HL) in DFNA9 patients, but much lower than that in 
DFNA2 patients (65 dB).13 On the other hand, the deterioration gradient in our DFNA5 
patients (0.4%/dB) was fairly similar to that in our DFNA2 patients (0.5%/dB), whereas it was 
lower than that in our DFNA9 patients (1 2%/dB).13 At similar PTA, 2 A kHz levels (>60 dB), the 
maximum phoneme scores of our DFNA5 patients were in between those of our DFNA2 and 
DFNA9 patients (data not shown). 
We previously suggested that DFNA2/KCNQ4-re\a\edi high-frequency sensorineural 
hearing impairment can be attributed to a lack of expression of K+ channels in mutation 
carriers, especially in inner hair cells of the lower cochlear turns.13 Relative sparing of outer 
hair cell function in these patients could account for their relatively good speech recognition 
scores. We speculate that DFNA5 patients retain relatively good speech recognition scores 
on a similar basis. Hopefully more detailed expression studies will clarify this issue in the 
near future. 
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Introduction 
A large American kindred segregating for autosomal dominant non-syndromic 
sensorineural hearing impairment was used to map the DFNA10 locus.1 The candidate 
region on chromosome 6q was reduced by expanding this pedigree2 and identifying a second 
DFNA10 family from Belgium (Figure 1). Both families carry mutations in EYA4 (eyes-absent 
gene), which belongs to a family of transcriptional activators that are involved in embryonic 
development.3 As EYA4 gene expression has also been detected in the adult cochlea (at 
least in the mouse), it is equally possible that the main role of this gene lies in the 
maintenance of the auditory system rather than in its development. Linkage to DFNA10 has 
also been suggested in a Norwegian family, but an EYA4 mutation has not been detected 
herein (personal communication by Lisbeth Tranebjaerg, Toni Fagerheim). 
The hearing impairment characteristics of DFNA10 have been described in detail.45 
In this report, we provide the main phenotypic features of both DFNA10 families and 
compare them statistically. 
Patients and Methods 
We obtained audiologic data from American and Belgian family members segregating 
for two DFNA10 EYA4 deafness-causing mutations, the insertion of two adenine residues at 
position 1468 (1468insAA) in the American family and a cytosine-to-thymme transition at 
position 2200 (2200C>T) in the Belgian family. Both mutations cause premature stop codons. 
We excluded all persons whose hearing impairment might have been caused by other, non-
hereditary factors. 
Pure-tone hearing thresholds were analyzed in relation to age (linear regression 
analysis) to construct age-related typical audiograms (ARTA) at 10, 20, 30, 40, 50, 60 and 70 
years for each family. We tested whether regression lines between both families were 
significantly different for each frequency and calculated the pooled ATD (Annual Threshold 
Deterioration) where possible (analysis of covanance, ANOVA, Prism 3.02 program, 
GraphPad, San Diego, CA, USA). 
Results 
We tested 25 affected persons from the American family4 and 17 affected persons 
from the Belgian family.5 The median age and age distribution were similar in both families. 
Audiograms exhibited minimal mteraural differences and for this reason, only data pertaining 
to the right ear were used for analyses 
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Figure 1: Pedigree of the Belgian (B) DFNA10/EV/44 family. EYA4 mutation carriers of whom an 
audiogram was included are numbered. Filled symbols indicate hearing impairment. The offspring of 
non-affected persons are not depicted. 
The audiometrie pattern in the hearing impaired persons in the American family 
evolved from flat-to-gently sloping (< 50 years) to steeply sloping with advancing age (> 50 
years). Individual audiograms in the Belgian family (Figure 2) showed a mid-frequency to 
gently downslopmg configuration (< 50 years) that progressed to a gently-to-steeply sloping 
configuration (> 50 years). 
ARTA (Figure 3) in both families demonstrate flat-to-gently sloping features, which 
result eventually in steeply sloping audiograms. The hearing loss in the American family 
(Figure 3, A) appears to be slightly more severe than in the Belgian family (Figure 3, B). The 
Belgian ARTA pertaining at 10 years is not included as the youngest Belgian participant was 
only 20 years old. 
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8 kHz 8 kHz 
Figure 3 (A, Β) Age-Related typical audiograms (ARTA) of the American (A) and Belgian family (B) 
Italics indicate age in years 
Despite apparent differences in ARTA, we generally found no significant difference in 
intercept nor in slope (ATD) between the regression lines The pooled ATD was 0 8 dB/year, 
although a much higher progression was recorded in the first two decades of one person in 
the American family4 The trait is believed to have a postlingual onset in both families as all 
members had developed normal language and speech skills 
Tinnitus was present in 35% of the Belgian family members Only one person in each 
family mentioned sporadic vestibular problems, although vestibular function was not formally 
tested 
Conclusions 
Both families segregating for hearing loss at the DFNA10 locus presented with flat-to-
gently sloping audiograms that became steeply sloping with increasing age Consistent with 
the genotypic finding that affected persons in both families carry mutations that lead to 
premature stop codons m EYA4 is the phenotypic finding that the typical audiogram from 
each family shows only minor differences in threshold and exhibits only limited progression 
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Abstract 
We present a detailed analysis of the DFNA10 phenotype based on data from 25 hearing-
impaired persons belonging to a large American pedigree segregating for deafness at the 
DFNA10 locus (chromosome 6q22.3-23.2). Cross-sectional analysis of air conduction 
threshold-on-age data from all available last-visit audiograms (linear regression analysis, age 
over 15 years) showed progression of heanng loss at a rate of 0.6 dB/year over all 
frequencies, with a flat to gently sloping age-corrected threshold of about 50 dB. The results 
were significant at 0.25, 4 and 8 kHz, but only if corrections for presbyacusis were not 
included. Longitudinal threshold analysis performed in 1 case, covering age 6-32 years, 
showed progression of hearing loss at a rate of 2-3 dB/year over 0.25-8 kHz. Nonlinear 
regression analysis was performed on phoneme recognition scores with use of sigmoidal 
dose-response curves with variable slope. On the basis of these data, the hearing loss 
phenotype in this American DFNA10 family can be described as postlingual, initially 
progressive, and resulting, without the influence of presbyacusis, in a largely stable, flat 
sensorineural deafness. 
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Introduction 
Genetic linkage techniques have facilitated the identification of genes essential for 
normal auditory function The initial step in this process is the localization of relevant genes 
by classic linkage analysis Since 1992, 39 loci for autosomal dominant non-syndromic 
sensorineural hearing loss have been mapped, and 11 of the relevant genes have been 
cloned An update of these genetic data can be obtained by consulting the Hereditary 
Hearing Loss Homepage ' 
The identification of these genes has been facilitated by detailed descriptions of the 
hearing loss phenotype The value of these clinical data is paramount, as the inability to 
recognize phenocopies in linkage analysis precludes a successful outcome In addition, with 
detailed audiometrie data, possible phenotypic-genotypic correlations can be explored 
In 1996, the DFNA10 (DFN, deafness, A, autosomal dominant, 10, 10lh autosomal 
dominant locus discovered) locus was mapped to chromosome 6q22 3-23 2 in an American 
family2 Additional fieldwork has enabled us to expand the pedigree to include more than 
200 persons In this article, we provide a detailed description of the deafness phenotype that 
is segregating in this family 
Patients and Methods 
Subjects in the DFNA10 American kindred were identified with the assistance of one 
family member who maintained a detailed archive of the pedigree that covered approximately 
2 centuries (Figure 1) Numerous family branches were identified in which hearing loss was 
segregating In these branches, both affected and non-affected persons were contacted 
In 27 affected persons, pure-tone and speech audiograms were obtained by standard 
procedures, bone conduction levels were evaluated only to exclude conduction loss Thirteen 
persons also had tympanograms and acoustic middle-ear reflex measurements, 5 persons 
had serial audiometry By historical data and physical examination, there was no evidence to 
suggest that the hearing loss was syndromic Each affected person also shared a common 
genotype within the DFNA10 interval2 Two persons were suspected of having additional 
non-hereditary hearing problems and were excluded from the audiological analysis 
Audiometrie configuration and threshold asymmetry were evaluated according to the 
criteria and classification established by the European Work Group on Genetics of Hearing 
Impairment3 Air conduction thresholds (decibels hearing level [HL], last visit) were used for 
cross-sectional linear regression analysis (threshold-on-age, age range 15-87 year) with a 
commercial program (Prism 2 01, GraphPad, San Diego Ca, USA) Where relevant, out-of-
scale measurements were included and fixed at an arbitrary level of 130 dB HL The 
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threshold at each frequency was tested for significant progression (regression coefficient > 
0). The Prism program's F test option for comparing regression lines was used to identify 
lines that could be pooled. 
Figure 1: Simplified pedigree of the American DFNA10 family Only 1 branch is shown in full. 
Participants are indicated by letters (descendants are indicated with lower case letters). Filled symbols 
not accompanied by a letter are considered affected by history. 
To detect progression beyond presbyacusis, analyses were repeated with corrected 
values (measured thresholds minus age-and-sex adjusted median thresholds according to 
ISO 7029 norms4). Two persons aged more than 70 years old were excluded, as there are 
no presbyacusis norms available for their age. In the absence of significant progression, we 
constructed a "mean audiogram" by compiling all age-corrected threshold data. One-way 
analysis of variance (ANOVA) was used to detect significant differences between thresholds 
at each frequency. Pooling was performed only where permitted according to the results of 
such tests. 
Longitudinal linear regression analysis (threshold-on-age) was performed in 3 
patients. Cross-sectional (last visit) phoneme recognition scores (phonetically balanced word 
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test, PB-50) were analyzed in relation to age and pure-tone average of the thresholds at 1, 2 
and 4 kHz (PTA, 24 kHz) PTA levels were included only if at least 2 of the 3 frequencies 
involved had been measured Nonlinear regression analysis was performed using a 
sigmoidei response curve with variable slope 5 ANOVA and Student's t test (with Welch's 
correction if Bartlett's test demonstrated significantly unequal variances) were used to 
compare results with those we obtained in a group of 46 controls with only presbyacusis 
(author's unpublished data) 
Results 
All of the hearing-impaired persons dated their first symptoms of hearing loss within 
the first 3 decades of life Apart from episodic vertigo with temporary imbalance in 1, none 
experienced additional relevant symptoms As is typical of persons with other types of post-
lingual hearing impairment, all also had normal speech and language development 
Audiograms are shown in Figure 2 (cases Α-Y) As only 3 persons had substantial 
mtra-aural threshold asymmetry (not shown), only data pertaining to the right ear were 
analyzed The bone conduction thresholds and tympanograms (data not shown) were 
consistent with the pure-tone threshold data The acoustic middle-ear reflexes were normal, 
assuming a maximum of 100 dB 
Almost 40% of the subjects (cases C, L, N, R and U-Y) showed steeply sloping 
audiograms This configuration was present in θ of the 14 persons more than 50 years old 
(cases L, N, R and U-Y), but only in 1 of the 11 younger persons, a significantly different 
prevalence (Fisher's exact probability test, Ρ = 0 017) Seven persons had a gently sloping 
configuration (cases D, F, H, J, Κ, M and S, ages 31 to 57) In 5 persons (cases A, E, G, I 
and P), the configuration could not be clearly classified, as it was intermediate between the 
flat and gently sloping types3 Four persons (cases B, O, Q and T, ages 29 to 58) had flat 
pure-tone audiograms 
Of the 5 persons with serial audiometry (F, Κ, Ο, Ρ and U), 3 (F, Ο and P) had a 
sufficient number of audiograms covering a sufficiently wide age interval for longitudinal 
analysis Both cases Ο and Ρ showed progression of about 2 dB/y, which was significant 
only in case Ο The longitudinal analysis of case F is combined in Figure 3 with the overall 
cross-sectional linear regression analysis This figure shows a sharp increase in threshold in 
the second and third decades of life (ι e of case F) The thin trend line connects the data 
points (squares) obtained by separately averaging the threshold and age values for the first 2 
and the last 4 measurements The derived mean threshold deterioration was approximately 2 
to 3 dB/year at 0 25 to 8 kHz Between the 2 "baseline" measurements (at ages 6 and 16, 
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also see Figure 2), a considerable number of audiograms were obtained from case F as she 
had middle ear effusions; the data during this interval have been excluded from the analyses. 
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Figure 2: Audiograms (air conduction threshold m decibels Hearing Level m the right ear) in cases A 
through Y. Roman numeral is person's generation number and is followed by sex (F; M). Note that 
audiograms are ordered by age (y = year) at last visit 
The cross-sectional analysis (circles and bold solid lines) disclosed significant 
progression at 0.25, 4 and 8 kHz (Figure 3). The annual threshold deterioration (ATD) pooled 
for all frequencies was approximately 0.6 dB/y. After correction was made for presbyacusis 
(asterisks and dotted lines), the significance of progression vanished; the pooled ATD was 
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only about 0 1 dB/y Thus we concluded that there was no substantial progression beyond 
presbyacusis between age 30 and 70 years. Case A (age 15 y) showed considerable 
asymmetry; exceptionally high thresholds were only seen in the right ear. The age-corrected 
thresholds of all individuals included in the cross-sectional analysis are incorporated in the 
"mean audiogram" (mean age 47 6 y), shown in Figure 4. 
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Figure*. Mean, age-corrected audiogram. 
Figure 5 shows the development of phoneme recognition scores in relation to age (A) 
and PTA level (B). The 50% score was attained at age 67 years, whereas in the 
presbyacusis group this score was attained at 89 years (significantly different, standard 
errors not shown). In the score-against-PTA plots, the sigmoidal curves in the groups of 
DFNA10 and presbyacusis patients were fairly similar: the 50 % value was found at 90 dB in 
the DFNA10 group and at 86 dB in the presbyacusis group. 
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Figure 5 (A, B): Plot of phoneme discrimination scores in the right ear against age (A) and 
corresponding PTA124 kHz level (B). Solid lines were fitted with a sigmoidal dose-response equation 
with variable slope; dotted lines indicate the inflection point (50% score) 
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Discussion 
The hearing loss phenotype in this American DFNA10 family is postlingual, 
progressing to a largely stable flat sensorineural hearing loss on which presbyacusis-
associated changes can be superimposed Admittedly, in the absence of enough data in the 
0 to 10 year age range, there is only circumstantial evidence for the postlingual onset 
However, longitudinal analysis of case F is consistent with hearing acuity that is normal in 
childhood but begins to deteriorate relatively early After the age of 30 years, the loss 
becomes stable, apart from decrements due to presbyacusis 
The progressive sensorineural deafness in persons affected by DFNA10 initially 
occurs without loss of speech recognition, however speech recognition drops as 
presbyacusis aggravates the loss When thresholds go beyond 50 dB across frequencies, 
deterioration in speech recognition scores is evident Although this deterioration occurs at a 
younger age than usual, the rate of deterioration is consistent with the added effects of 
presbyacusis When we fit parabolas of the form Y = Offset + Acceleration(Age - 18)2 to the 
threshold-on-age data of DFNA10-affected persons (based on equations in the ISO 7029 
norm for presbyacusis4), at each frequency, Offset is fairly similar to values shown in the 
mean audiogram (data not shown) From that level onwards, thresholds increase along the 
parabolic curves with the person's age approximately in parallel with classic presbyacusis 
parabolas 
This observation means that the decline in hearing threshold with advancing age in 
DFNA10-affected persons is a combination of a stationary onset level attained during the first 
few decades of life (the inherited DFNA10 effect) and normal presbyacusis After the age of 
30 years, the hearing loss shows no progression of significance other than what would be 
expected from presbyacusis Persons with DFNA10 and presbyacusis show similar abilities 
to recognize phonemes in relation to the pure-tone-threshold levels This finding suggests 
that DFNA10 is like presbyacusis in the sense that we are dealing with a primary cochlear 
dysfunction The progressive but self-limiting nature of this loss is intriguing 
It is possible that premature outer hair cell damage is the basis for the DFNA10 
phenotype, as dysfunction at this level would result in thresholds similar to those we have 
observed in this family Once the DFNA10 gene has been cloned, in situ hybridization 
experiments can be performed to determine where transcripts localize within the cochlea 
These data, and the clinical results presented here, will improve our understanding of 
deafness at the DFNA10 locus and provide us with a clearer picture of normal inner ear 
function 
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Addendum 
Recently the DFNA10 gene was identified as EYA4 (Wayne S, Robertson NG, Declau F et al 
Mutations in the transcriptional activation EYA4 cause late-onset deafness at the DFNA10 locus Hum 
Mol Genet 2001, 10 195-200) 
102 
DFNA10/EWW 
References 
1 Van Camp G, Smith RJH Hereditary Hearing Loss Homepage World Wide Web URL 
http //dnalab-www uia ac be/dnalab/hhh/ 
2 O'Neill ME, Marietta J, Nishimura D, Wayne S, Van Camp G, Van Laer L, Negnni C, Wilcox, ER, 
Chen A, Fukushima K, Ni L, Sheffield VC, Smith RJH A gene for autosomal dominant late-onset 
progressive non-syndromic heanng loss, DFNA10, maps to chromosome 6 Hum Mol Genet 
1996,5 853-856 
3 European Work Group on Genetics of Heanng Impairment, Infoletter 2, November 1996 
4 ISO 7029 Acoustics Threshold of hearing by air conduction as a function of age and sex for 
otologically normal persons Geneva, Switzerland International Organization for Standardization, 
1984 
5 Motulsky HJ Intuitive biostatistics Oxford University Press, New York, 1995 ISBN 0-19-50-8607-
4 
103 

Chapter 5 
DFNA13/C0/.77>!I2 

The phenotype of DFNAia/COLJM* 
EMR De Leenheer, WT McGuirt, HPM Kunst, PLM Huygen, RJH Smith, CWRJ Cremers 
Advances in Oto-Rhino-Laryngology The clinical presentation of genetic hearing impairment 
Basel, Karger 2001, vol 60 In press 
Chapter 5.1 
Chapter 5.1 
Introduction 
In 1997, the 13,h locus implemented in non-syndromic autosomal dominant inherited 
sensorineural hearing impairment was mapped to chromosome βρ' in a large American 
kindred (Figure 1A). Expansion of this family and addition of another unrelated Dutch 
DFNA13 family (Figure IB) made it possible to refine the locus and eventually to identify the 
responsible gene as COL11A22 
The COL 11A2 gene encodes the oia (XI) chain of type XI collagen, which is essential 
for the orderly spacing of type II collagen fibers. Mice deficient in Col11a2 exhibit hearing 
loss and an altered structure of the tectorial membrane.2 A mutation in C0L11A2inas been 
identified in persons with the non-ocular form of Stickler syndrome3 and otospondylo-
megaepiphyseal dysplasia (OSMED syndrome)." 
Extensive audiometrie studies have been performed in both DFNA13 kindreds.56 We 
summarize and compare the phenotypic data. 
Patients and Methods 
Hearing thresholds previously obtained in persons with a COU1A2 mutation from the 
American and Dutch DFNA13 families56 were collected. American mutation carriers have a 
C-to-T transition in exon 42, which results in an arginme-to-cysteine substitution of the 
expressed protein, while Dutch carriers have a G-to-A transition in exon 31, causing a 
glycme-to-glutamate substitution.2 All subjects had undergone a general otorhinolaryngo-
logical examination to exclude non-hereditary causes of hearing impairment. Audiograms 
were recorded using standard procedures. 
Pure-tone hearing thresholds (left ear only) were analyzed in relation to age (linear 
regression analysis) to construct age-related typical audiograms (ARTA) pertaining to age 
10, 20, 30, 40, 50, 60 and 70 years for the separate families. For each case, a suitable age 
was selected that allowed for longitudinal regression analysis. To assess the influence of 
presbyacusis, we subtracted the age-and sex-specific ISO 7029 median (P50) threshold for 
presbyacucis from the ARTA thresholds. To evaluate progression, linear regression analyses 
were performed on thresholds without and with presbyacusis correction.56 Vestibular testing 
also was performed in 17 mutation carriers from the Dutch family using described methods.5 
Results 
Data from 20 persons from each family were included. Individual audiograms from the 
Dutch family are presented in Figure 2. Please note that case 17 of the Dutch family, who 
previously5 showed an atypical phenotype, has developed hearing loss. 
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Figure 1 (A, By. Pedigree of the Amencan (A) and Dutch (Β) DFNA13/COLr 1A2 family. COL 11A2 
mutation carriers of whom an audiogram was included are numbered. Filled symbols indicate hearing 
impairment. The offspnng of non-affected persons are not depicted. 
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Overall, the audiometrie configuration was rather variable, although most affected persons 
from the American pedigree showed a mid-frequency bias, while most Dutch individuals with 
DFNA13 exhibited a slightly downslopmg audiogram. The mid-frequency loss was most 
obvious in the youngest members of both families. An additional feature, in especially the 
younger affected Dutch family members, was better hearing levels between 2, 4 and 
sometimes 6 kHz as compared to 1 and 2 kHz. 
Figure 3 shows the ARTA for the American family (Panel A) and the Dutch family 
(Panel B). The hearing deficit is presumed to exist from an early age onwards in both 
families. By correcting the ARTA thresholds for presbyacusis, the mid-frequency features 
became more pronounced (data not shown) with a maximum threshold at roughly 30-40 dB 
in both families. Additional high-frequency impairment persisted in the Dutch family. 
Both hearing impairment traits were stationary. There was no significant progression 
beyond that attributable to presbyacusis. Interestingly, the progression of hearing loss in the 
American family appeared less severe than normal for the high frequencies. 
Caloric abnormalities5 occurred in 8 of 17 persons tested in the Dutch family, but 
none had any substantial vestibular impairment symptoms. 
A Β 
dB HL dB HL 
8 kHz 8 kHz 
Figure 3 (A, By Age-related typical audiograms (ARTA) of the American (A) and Dutch (B) family. 
Italics indicate age in years. 
Conclusions 
DFNA13 hearing loss in the American family is a non-progressive, presumably 
congenital, mid-frequency sensorineural hearing impairment. In the DFNA13 Dutch family, 
features are similar, but there is an additional high-frequency loss. 
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Abstract 
Objective To analyze the phenotype in a 5-generation DFNA13 family with a missense 
mutation in the COL11A2 gene that causes autosomal dominant, presumably prelmgual, 
non-syndromic sensorineural hearing impairment 
Design Family study 
Setting University hospital department 
Patients Twenty mutation carriers from a large American kindred 
Methods Cross-sectional analysis using pure-tone threshold measurements at 0 25, 0 5, 1, 
2, 4 and 8 kHz The audiometrie configuration was evaluated according to an existing 
consensus protocol The significance of features relating to audiometrie configuration was 
tested using 1-way analysis of variance Progression was evaluated with linear regression 
analyses of threshold-on-age 
Results Most individuals showed mid-frequency (U-shaped) characteristics The mean 
threshold in generations IV and V was 44 dB at 1, 2, and 4 kHz (mid-frequencies), it was 29 
dB at the other frequencies (0 25, 0 5 and 8 kHz) There was no significant progression 
beyond presbyacusis 
Conclusion The trait in this family can be characterized as autosomal dominant, non-
progressive, presumably prelmgual, mid-frequency sensorineural hearing impairment 
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Introduction 
Genetic linkage techniques have facilitated the identification of genes essential for 
normal auditory function The initial step in this process is the localization of these genes 
using classic linkage techniques, since 1992, 38 loci for autosomal dominant non-syndromic 
sensorineural heanng loss have been mapped, and 11 of the relevant genes have been 
cloned The different gene loci for the nonsyndromic forms of hearing impairment have been 
called DFN (DeaFNess) and are numbered in chronological order of discovery Autosomal 
dominant loci are referred to as DFNA, autosomal recessive as DFNB, and X-lmked as DFN 
An update of these genetic data can be obtained by consulting the Hereditary Hearing Loss 
Homepage 1 
The identification of these genes, in turn, has prompted studies to determine whether 
phenotypic-genotypic correlations exist It is well known that different mutations in the same 
gene can produce a broad spectrum of phenotypes 2 For example, mutations in the myosin 
VIIA gene (MY07A) cause Usher syndrome type 1B,3 DFNB245 and DFNA11,5 and 
mutations in the Pendred Syndrome gene (PDS) cause Pendred syndrome7 and DFNB4β 
Mutations in the COL 11A2 gene also cause both syndromic and non-syndromic hearing loss 
Two DFNA13 kindreds, one American9 and the other Dutch, recently were shown to 
have missense mutations in the COL11A2 gene ι α The COL11A2 gene encodes the a.2 (XI) 
chain of type XI collagen Type XI collagen is a minor fibrillar component of cartilage 
collagen Mice with a targeted disruption of the col11a2 gene have hearing loss, and by 
electron microscopy, loss of organization of the collagen fibrils in the tectorial membrane 10 
A mutation in the COL11A2 gene was also identified as the cause of hearing 
impairment in persons with Stickler syndrome type 2 (STL2)1 1 1 2 This autosomal dominant 
syndrome is characterized by hearing impairment, midface hypoplasia and arthropathy, but 
in contrast to the classical form of Stickler syndrome, there is no ocular involvement, 
reflecting absence of COL11A2 gene expression in the vitreous 13 Hearing loss in patients 
with STL2 is reported mostly mild-to-moderate, sensorineural or mixed " 1 4 1 5 An autosomal 
recessive syndrome, otospondylomegaepiphyseal dysplasia which includes otospondylo-
facial dysplasia, bone dysplasia, mid-face hypoplasia and deafness, also can be caused by 
COL 11A2 gene mutations 1 2 1 6 
To establish whether phenotypic-genotypic correlations exist, it is imperative to 
describe phenotypes, based on their genotypes, as thoroughly as possible We present 
herein a detailed analysis of the clinical data of the American DFNA13 family, and relate 
these phenotype findings to the other COL11 A2-\\nked disorders 
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Patients and Methods 
An American family spanning 5 generations and comprising 67 members alive (Figure 
i)10, showed autosomal dominant sensorineural hearing impairment, presumably affecting 38 
persons (15 by history). Forty persons underwent general and otorhinolaryngological 
examinations, including audiometry. Individual V-13 was excluded from the study because 
the reliability of the hearing test was questioned. Genetic linkage analysis was performed 
and the hearing loss segregated with markers on chromosome 6p21-22; this locus was 
designated DFNA13.9 Recently, a missense mutation in the COL 11A2 gene was reported in 
this family.10 Two phenocopies (individuals III-8 and 111-17) were identified. They had hearing 
loss confirmed by audiograms, but lacked the gene mutation; their audiograms could not be 
distinguished from those in the mutation carriers. 
Figure 1: Pedigree of the American DFNA13 family; Roman numerals indicate different generations; 
sqaures, men; circles, women; solid symbols, hearing impairment; +, gene carriers; and a, audiogram 
available. All individuals in generations I and II (except II-2) and person 111-13 are deceased. 
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The present analysis of the hearing phenotype includes only those persons carrying 
the COL11A2 gene missense mutation from whom at least one audiogram had been 
obtained (n=20). Corrections were made for presbyacusis by subtracting the ISO 7029 
median (50th percentile, P50) threshold for presbyacusis17 from each person's threshold, 
according to that person's age and sex. For persons older than 70 years, the P50 values for 
age 70 years (the maximum age for which normative data are available) were used. 
Audiograms (air conduction threshold in decibels hearing level) were recorded in a sound-
shielded room following common clinical standards. 
Audiometrie configuration was classified according to the criteria formulated by the 
European Work Group on Genetics of Hearing Impairment.18 Mid-frequency hearing 
impairment (a U-shaped audiogram) is defined as follows: a 15-dB difference or greater 
between the poorest thresholds in the midfrequencies (> 0.5 to 2 kH z) and those at higher 
and lower frequencies. The low-frequency ascending pattern is defined as a difference of 15 
dB or greater between the thresholds at the poorer low frequencies and the higher 
frequencies. A flat audiogram is defined as a difference of less than 15 dB from 0.25 to 8 
kHz. High-frequency hearing impairment is subdivided into gently and steeply sloping 
configurations. The former type is defined as a 15- to 29-dB difference between the mean of 
0.5 and 1 kHz and the mean of 4 and θ kHz, while the latter implies a 30-dB difference or 
greater between the described frequencies. 
One-way analysis of variance and regression analyses were performed on cross-
sectional threshold-on-age data (last-visit audiogram), using a commercial program (Prism, 
PC version 2.01; GraphPad, San Diego Calif.). To evaluate whether significant progression 
(slope > 0) occurred, linear regression analysis was performed using only the raw threshold-
on-age data in generations IV and V (age range 11-48 years); the affected persons in 
generation III (age range 67-75 years) were substantially older. By excluding generation III, 
the potentially confounding effects of presbyacusis were avoided. All threshold-on-age data 
were used in an attempt to fit parabolic curves, similar to the fits on which the ISO 7029 
norms17 are based: Y = offset + a(X-18f, where Y is the binaural mean air conduction 
threshold (measured in decibels), X is age (in years), and a is acceleration of hearing 
deterioration (measured as decibels times years negatively squared). Chauvenet criterion 
was used to detect any outlying values, i.e. data points pertaining to excessively large 
regression residues.19 We also determined whether each ISO 7029 value for a17 was within 
the calculated 95% confidence interval for a (t distribution). 
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Figure 2: Air conduction threshold (dB HL, bold lines and circles), together with the threshold minus 
the 50th percentile (P50) of presbyacusis (thin line and asterisks) for that person's age and sex in 20 
affected persons. Case number (1-20), individual number in pedigree (III-1 -> V-12), sex (M, F), age 
(y) and ear (L/R) are indicated. 
Results 
All 20 persons examined and known to carry the COL11A2 mutation showed 
sensorineural hearing impairment {Figure 2). The individuals are given in ascending order of 
age at the last visit. Classification of audiometrie configuration was based on the original data 
(i.e. without presbyacusis correction). Of the 40 ears, 17 showed a U-shaped audiogram (R, 
right; L, left; Cases 1 RL, 2 RL, 4 L, 6 RL, 7 RL, θ L, 9 L, 10 RL, 13 RL, 14 L, 15 L). Other 
audiometrie types included: a flat configuration in 6 ears (Cases 12 RL, 18 RL, 20 RL); gently 
down-sloping in 3 ears (Cases 3 R, 8 R, 11 R); and steeply down-sloping in 4 ears (Cases 17 
RL, 19 RL). The latter persons had a history of significant noise exposure. Low-frequency 
ascending curves were found in 3 ears (Cases 5 RL, 14 R), and in 7 ears (Cases 3 L, 4 R, 9 R, 
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11 L, 15 R, 16 RL) the audiometrie configuration could not be classified The ears 15 R and 16 
RL showed a threshold curve that gently sloped from the low frequencies to a dip at 4 kHz 
but ascended at θ kHz In the last 3 individuals, there was no history of noise exposure In 4 
ears (Cases 3 L, 4 R 9 R 11 L), although the configuration was gently down-sloping, the 
degree of slope did not meet the classification criterion In some persons (ι e the oldest 
patients), presbyacusis correction changed the audiometrie configuration In cases 17, 18 and 
19, the audiogram could no longer be classified In person 18, the audiometrie curve was 
similar to those seen in cases 15 R and 16 RL, but with a dip at 2 kHz After correction for 
presbyacusis, case 20 fitted the description of a low-frequency ascending curve 
While the audiometrie configuration was variable, the predominant type was identified 
as U-shaped (42 5%, 17 of 40 ears), even including data corrected for presbyacusis The 
"mean audiogram" also showed a U-shaped configuration (Figure 3), the thresholds at 0 25-4 
kHz differed significantly from 0 The mean thresholds at 0 25, 0 5 and 8 kHz appeared fairly 
similar (mean about 29 dB) and so did the mean thresholds at the frequencies 1-4 kHz 
(mean about 44 dB) Thus the difference between these grouped frequencies (15 dB) 
complied with the definition of a U-shaped configuration These (raw) data (Figure 3) cover 
only generations IV and V to avoid any major influence of presbyacusis 
Analysis of variance disclosed significant mtragenerational and thus age-related differences 
in threshold (raw data) for a given frequency (data not shown) Linear regression analysis 
was performed on the raw threshold-on-age data in the combined generations IV and V Only 
the 0 5 kHz frequency showed mild, but significant progression (0 3 dB per year), which 
vanished following presbyacusis correction (data not shown) 
dB HL 
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Figure 3 The "mean audiogram" ± 1 SD based on the raw thresholds of the analyzed cases in 
generations IV and V 
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Figure 4 Analysis of progression in threshold (circles indicate the raw binaural mean threshold for air 
conduction) with advancing age A, 0 25 kHz, B, 0 5 kHz, C, 1 kHz, D, 2 kHz, E, 4 kHz, and F, 8 kHz 
The continuous curve is the fitted parabola for the present patients (men and women), and the dashed 
(women) and dotted (men) curves are the parabolas for ISO 7029 norms given the same offset as the 
patients The asterisk in A and Β represent outlying values (one case excluded from the analyses) 
The age-corrected threshold shows ascending characteristics in generation III (Figure 
2), which would have been even stronger if we had been able to use appropriate P50 values 
for the persons older than 70 years (cases 18-20) We attempted to circumvent this limitation 
by fitting ISO 7029 presbyacusis parabolas to the threshold data, as described in the 
"Patients and Methods" section (Figure 4) The fitted offset values were included in the 
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parabolic fit according to the usual median (P50) presbyacusis norms The curves thus 
obtained were used to compare the apparent age-related progression with the expected 
progression in presbyacusis 
The threshold data (Figure 4) behave very similar to presbyacusis in the mid-
frequency range (1-2 kHz) At 0 25 kHz, the ISO 7029 acceleration coefficient a (0 0030 
dB y2 for both men and women) is below the lower limit of the 95% confidence interval of the 
fitted value (0 0093 dBy2 , 95% confidence limits 0 0056-0 013) The same applies to the 
values at 0 5 kHz (ISO 7029 value 0 0035 dB y2, fitted value 0 0075 dB y2, confidence limits 
0 0046-0 010) At an age relating to generation III, the difference is maximal (Figure 4, top 
panels) The thresholds at 4 and 8 kHz show accelerations that are fairly close to those in 
normal women (bottom panels of Figure 4, generation III), although there were more men 
(n=14) than women (n=6) in our series 
Discussion 
The DFNA13 locus originally was mapped to chromosome 6p using a portion of this 
American family9 Expansion of the pedigree permitted locus refinement and eventually, the 
demonstration of a missense mutation in the COL11A2 gene that segregated with the 
hearing-loss phenotype 10 The mutation, a C-to-T transition in exon 42, results in an argmme-
to-cysteme substitution The hearing loss may be caused by altered type II collagen spacing 
in the tectorial membrane, as suggested by histopathological and electron microscopic 
findings in mice with a coll 1a2 mutation ,0 
The phenotypic characteristics of the family have been described only briefly,10 and 
the results of this study complement that description in detail The sensorineural hearing 
impairment segregating in this family is autosomal dominant, presumably prelmgual, and 
non-progressive, and it affects the mid-frequency range Our presumption that it is prelmgual 
is based on its lack of progression and our finding of a mean threshold in the younger 
generations that differs significantly from 0 
This pattern of hearing loss is very similar to the hearing loss in the only other 
DFNA13 family (a Dutch kindred) that is known to segregate for a COL 11A2 gene mutation 20 
Affected persons in the Dutch family carry a G-to-A transition in exon 31 of the COL11A2 
gene that results in a glycme-to-glutamate ammo acid substitution Their sensorineural 
hearing loss is presumably prelmgual and clearly non-progressive Like their affected 
American counterparts, affected Dutch persons present with mid-frequency loss Age-
corrected thresholds, however, are about 10 dB better at 0 25 to 4 kHz and about 25 dB 
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worse at 8 kHz. This additional high-frequency hearing impairment in the Dutch family 
persists after correction for presbyacusis. 
Syndromic COL 17/42-associated hearing loss is somewhat different. As reported by 
Admiraal et al.15 in their study of a Dutch family with STL2 carrying a G-to-A transition that 
causes in-frame skipping of a 54-base pair exon encoding 18 ammo acid residues within the 
triple-helical and C-propeptide domains of the a2(XI)collagen molecule,'2 the mean 
sensorineural threshold was 40 dB (n=14). There was no substantial progression, and the 
audiometrie configuration, as classified by criteria used in this study, showed substantial 
variability. Most cases were down-sloping, and in addition to sensorineural hearing 
impairment, almost half of affected persons showed a conductive loss, perhaps attributable 
to the associated features of STL2. A fairly similar type of hearing loss was reported in a 
second family with STL2 in whom an in-frame deletion removes 3 repeats of 2 unspecified 
amino acids and glycine in the midportion of the a2(XI) major triple-helical domain.14 
Progression in hearing impairment in the American family is similar to the ISO 7029 
standard curves for presbyacusis at 1 to 2 kHz (Figure 4C-D). At lower frequencies (0.25-0.5 
kHz), there is more progression than predicted by the ISO 7029 (P50) norm. At higher 
frequences (4-8 kHz), the parabolic curve for the combined group of male and female 
patients 's fairly similar to the standard presbyacusis norm for women, although there is a 
predomirance of men in our series. These findings suggest that presbyacusis in the 
American DFNA13 family is less severe than normal at the higher frequencies. 
The possibility that presbyacusis is milder in this family because of other, as yet 
umdentif ed, genetic factors cannot be excluded. It is intriguing, however, that fairly similar 
observat'ons have been reported in 2 other families with midfrequency hearing impairment at 
the DFISKS or DFNA12 locus.2122 These families, one Austrian and the other Belgian, show 
less proçiression of hearing loss with age than the normal population. Their deafness is due 
to mutat'ons in the α-tectorin gene (TECLA).23 Like the COL11A2 gene, the TECTA gene 
produces an important component of the tectorial membrane. Perhaps, by changing the 
mechanical properties of the tectorial membrane, it may be possible to modify the "wear-and-
tear" effects of age on auditory function. 
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Summary and conclusions 
Research into hereditary hearing impairment has become a hot topic in present-day 
science. With the development of genetic linkage techniques, it became possible to 
differentiate between several forms of hereditary hearing impairment, and a new 
classification system was bom. Current insights on hereditary hearing impairment are 
reviewed in Chapter 1 Further on, this thesis focuses on the clinical aspects, in relation to the 
genotype, of some forms of autosomal dominant, non-syndromic, sensorineural hearing 
impairment, namely DFNA2/KCNQ4 ~ DFNA9/COCH (Chapter 2), DFNA5/DF/V/A5 (Chapter 
3), DFNAIO/EYVW (Chapter 4) and DFNA13/COLiM2(Chapter5). 
The Netherlands perfectly meet the expectations of scientists interested in autosomal 
dominant non-syndromic hearing impairment as the country harbors a lot of large families, 
which can be easily traced and investigated, thanks to the limited distances. In order to 
enhance our knowledge on the genotypic and phenotypic aspects of autosomal dominant, 
non-syndromic hearing impairment, data on four large DFNA-families were collected. 
Unfortunately, as these families are still undergoing genetic analysis at the Nijmegen 
Otogenetic Laboratory, reports on the phenotype have to wait until that analysis has 
succeeded in identifying the responsible locus, and/or gene. 
The clinical reports given in this thesis are based on previously linked and, in most 
cases, genotyped families The data on the Dutch DFUA2/KCNQ4 family were collected 
during this project and referred for genetic analysis elsewhere (see below). 
Each chapter starts with a general phenotypic description of the respective genotype. 
The main clinical characteristics of DFNA2/KC/V04 (Chapter 2.1), DFNA5/DFNA5 (Chapter 
3.1), DFNA10/EY7W (Chapter 4.1) and DFNA13/COM1A2 (Chapter 5.1) are presented and 
discussed. To provide an overview as complete as possible, we collected data from relevant 
families all over the world. In addition, the literature on these families was reviewed and age-
related typical audiograms (ARTA) of each family were constructed. By doing so, the 
phenotypes of families with similar genotypes could be easily compared, and genotype-
phenotype correlations could be studied. 
Chapter 2 reports on DFUA2/KCNQ4 and DFNA9/COCH. The first subsection of this 
chapter compares phenotypes of eight DFNA2/KCNQ4 families (Chapter 2.1 ). In the second 
part a new DFNA2/KCNQ4 family is presented (Chapter 2.2). The pedigree of this large 
Dutch family was constructed with the aid of a family member. Blood samples were collected 
and several audiovestibular tests performed. Preliminary phenotypic analysis raised a 
suspicion of DFNA2/KCNQ4 related hearing impairment, and indeed, the Department of 
Medical Genetics of the University of Antwerp (Prof Dr G Van Camp) showed that 
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DFNA2/KCNQ4 was involved. Pure-tone hearing thresholds, speech recognition scores and 
vestibular responses were analyzed. Even though, at the time of the study, there were 
already three Dutch DFNA2/KCNQ4 families, with one of them harboring the exact same 
mutation (W276S) as our new one, the following two new findings were obtained. Sufficient 
longitudinal audiograms could be collected for the first time, and it appeared that the 
longitudinal analyses compromised the reliability of the cross-sectional analyses in the family 
concerned. Significant threshold progression (1dB/y) and offset (threshold at age 0) were 
clearly demonstrated. In addition, analyses of speech recognition scores showed that these 
did not deteriorate before the third decade of life. In order to relate the latter findings with 
other types of hereditary, high-frequency hearing impairment, more speech recognition 
scores of (Dutch) DFNA2/KC/\/04 families were (retrospectively) collected and compared 
with a group of DFNA9/COCH mutation carriers (Chapter 2.3). At similar levels of hearing 
impairment, DFNA2/KC/\/Q4 patients showed better speech recognition scores than 
DFNA9/COCH patients. At present, nine DFNA2//<'C/\/Q4 families have been identified. 
Interestingly, five of these families originate from the Netherlands and Belgium. It thus seems 
that KCN04 mutations are frequent in this region. Moreover, the mutation present in our 
family (W276S) was also the causative agent of hearing impairment in another (most 
probably) non-related Dutch family and a (most probably) non-related Japanese family, and 
may therefore be regarded as a potential hotspot for mutation in the KCNQ4 gene. 
Chapter 3 results from cooperation with the Department of Otolaryngology of the 
University of Utrecht (Prof Dr EH Huizing) and describes the DFNA5 phenotype in the only 
reported family with a mutation in the DFNA5 gene. Apart from outlining the general clinical 
features of DFNA5, we examined vestibular function, and found no evidence of vestibular 
involvement (Chapter 3.1). We also retrieved previously recorded speech recognition scores 
in the DFNA5 family (Chapter 3.2). Again, these speech recognition scores related to a 
specific type of high-frequency hearing impairment. Speech recognition in DFNA5 mutation 
carriers was relatively good, especially given their previously demonstrated rapid progression 
in hearing impairment, and, at similar levels of hearing impairment their scores were in 
between those in DFNA2/K'C/\/04 and DFNA9/COCH patients. 
Chapter 4 presents the clinical features of DFNAIO/EVTW. The general clinical 
features are based on the two DFNA10/EV/A4 families reported so far (Chapter 4.1). The 
Otogenetic Group of the University of Iowa (Prof Dr RJH Smith) had previously linked a 
large, American family to the DFNA10 region and provided the audiometrie data of this family 
(Chapter 4.2). Extensive analyses of these data showed postlingual, initially progressive 
sensorineural hearing impairment, which resulted without the influence of presbyacusis, in a 
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stable, flat loss. Furthermore, speech recognition scores deteriorated when (normal ?) 
presbyacusis aggravated the hearing loss due to DFNA10. Later, the Iowa group identified 
the EYA4 gene as responsible for DFNA10- related hearing impairment. 
Chapter 5 focuses on the clinical characteristics of DFNA13/COMÎA2. It includes a 
brief description of all families with hearing impairment caused by DFNA13/COZ.7//42 
(Chapter 5.1). Again, audiometrie data were obtained from the Iowa group (Prof Dr RJH 
Smith) that had previously linked the trait and now also identified the responsible mutated 
gene. The sensorineural hearing impairment trait segregating in this American family was 
defined as presumably prelingual, non-progressive, and affecting the mid-frequency range. 
In summary, the clinical aspects of the studied families have been outlined, and 
sometimes, complemented It is indeed of the utmost importance to present the phenotypes 
in relation to their respective genotypes as detailed as possible. Studying genotype-
phenotype correlations will, no doubt, enhance our understanding of normal and disturbed 
hearing processes. 
To date the number of so-called "deafness genes" is still increasing and many more 
"new genes" are expected to follow. Given the complexity of the auditory system, 
involvement of such a diversity of genes is not surprising. Nevertheless, the molecular basis 
of many key steps has yet to be established. Therefore, tracing, and analyzing - both in a 
genetic, as well as in a clinically oriented manner - new families, remains necessary. 
Furthermore, accurate descriptions of the corresponding phenotypes are still lacking for 
many genotypes, and clinicians should be stimulated to catch up with geneticists. Off course, 
progress in the field of deafness research is not only based on improvements in our basic 
(patho)physiological knowledge on the subject, but also on improvements in a more clinical 
point of view. The latter will lead to the classification of the different types of hereditary 
hearing impairment, insight into epidemiological data, the creation of molecular diagnostic 
tests, a higher quality of genetic counseling, and development of new therapeutics. 
Nowadays, molecular diagnostic testing for Connexin 26 (DFNB1, see Chapter 1) has 
become a routine procedure and already provides numerous parents of hearing impaired 
children with etiological answers. The future will most probably bring screening methods that 
are capable of identifying mutations that cause hearing impairment, so that the disorder is 
promptly diagnosed and can hopefully also be treated appropriately. Another important issue 
is to elucidate the mechanisms responsible for age-related hearing impairment. 
So, although substantial advance has been made recently, much work remains, and 
the implications to the practice of medicine are likely to be profound. 
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Het onderzoek naar erfelijke slechthorendheid is een populair ondenwerp geworden in 
de hedendaagse wetenschap. Met de ontwikkeling van genetische koppelingstechnieken is 
het mogelijk geworden om verschillende vormen van erfelijke slechthorendheid te 
onderscheiden en zo ontstond een nieuw classificatiesysteem. In Hoofdstuk 1 wordt een 
overzicht gegeven van onze huidige kijk op erfelijke slechthorendheid. Verderop gaat dit 
proefschrift dieper in op de klinische aspecten, in relatie tot het genotype, van sommige 
vormen van niet-syndromale, autosomaal dominante, perceptieve slechthorendheid, met 
name DFNA2JKCNQ4 ~ DFNA9/COCH (Hoofdstuk 2), DFNA5/DF/\M5 (Hoofdstuk 3), 
DFNA10IEYA4 (Hoofdstuk 4) en DFNA13/'COL 11A2 (Hoofdstuk 5). 
Onderzoekers die geïnteresseerd zijn in dit soort vormen van erfelijke 
slechthorendheid beschouwen Nederland als een ideaal land voor onderzoek, omdat er in 
Nederland nog steeds grote families te vinden zijn die, dankzij de beperkte afstanden en de 
aanwezige infrastructuur, gemakkelijk kunnen worden opgespoord en onderzocht. Om onze 
kennis betreffende de genotypische en fenotypische aspecten van autosomaal dominante, 
niet-syndromale slechthorendheid uit te breiden, zijn gegevens van vier grote DFNA-families 
verzameld. Het Otogenetisch Laboratorium te Nijmegen is momenteel nog bezig met de 
genetische analyses bij deze families; de beschrijving van de desbetreffende fenotypes 
hebben we daarom uitgesteld tot de resultaten van deze analyses bekend zijn. 
De klinische verslagen in dit proefschrift zijn gebaseerd op de beschikbare gegevens 
afkomstig van reeds gekoppelde families, waarbij in de meeste gevallen intussen ook het 
onderliggende gen werd geïdentificeerd. De gegevens over de Nederlandse DFNA2/KCNQ4 
familie zijn verzameld tijdens dit project, maar de genetische analyse is elders verricht (zie 
hierna). 
Elk hoofdstuk begint met een algemene beschrijving van het fenotype dat hoort bij 
een bepaald genotype. De belangrijkste karakteristieken van OFHA2IKCNQ4 (Hoofdstuk 
2.1), DFNA5/DF/\M5 (Hoofdstuk 3.1), DFNA10/EWW (Hoofdstuk 4.1) en DFNA13/COLÎ1A2 
(Hoofdstuk 5.1) worden besproken. Om een zo volledig mogelijk overzicht te kunnen geven, 
zijn gegevens verzameld, die afkomstig zijn van relevante families uit de gehele wereld. De 
literatuur over deze families wordt kort samengevat en leeftijdsgerelateerde typerende 
audiogrammen worden getoond. Op deze manier konden de fenotypes van families met 
gelijkaardige genotypes gemakkelijk vergeleken worden, alsook de genotype-fenotype 
correlaties bestudeerd worden. 
Hoofdstuk 2 beschrijft DFUA2/KCNQ4 en DFNA9/COCH. In het eerste deel van dit 
hoofdstuk worden de fenotypes van acht DFNA2/KCNQ4 families onderling vergeleken 
(Hoofdstuk 2). In het tweede deel wordt een nieuwe DFNA2/KCNQ4 familie gepresenteerd 
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(Hoofdstuk 2.2). De stamboom van deze grote Nederlandse familie is geconstrueerd met de 
hulp van een familielid. Vervolgens zijn er bloedmonsters afgenomen en is er 
audiovestibulair onderzoek verricht. Het fenotype wees in de richting van een aan 
DFUA2/KCNQ4 gerelateerd gehoorverlies. De afdeling Medische Genetica van de 
Universiteit van Antwerpen (Prof Dr G Van Camp) toonde inderdaad aan dat het hier om 
DFNA2/KCNQ4 gaat. Gehoordrempels, spraakaudiometne en vestibulaire responsies zijn 
geanalyseerd. Er waren reeds drie Nederlandse DFNA2/KCNQ4 families bekend, waarvan 
er één zelfs exact dezelfde mutatie (W276S) heeft als onze nieuwe familie. Desalniettemin 
konden de volgende twee nieuwe bevindingen worden verkregen. Voor het eerst kwamen er 
voldoende sene-audiogrammen beschikbaar. Op grond van de longitudinale analyses van de 
beschikbare audiogrammen ontstond er twijfel ten aanzien van de betrouwbaarheid van de 
cross-sectionele analyse van de gehoordrempels in deze nieuwe familie. Met statistische 
toetsing konden significante progressie in gehoorverlies (1dB per jaar) en een significante 
"congenitale" offset-waarde (drempel op leeftijd 0) worden aangetoond. De spraak-
herkenningscores waren normaal tot aan het begin van de derde levensdecade en namen 
daarna pas af. Om deze laatste bevindingen te relateren aan die bij andere types met erfelijk 
hoge-tonen gehoorverlies, verzamelden we (retrospectief) meer spraakherkenningscores 
van (Nederlandse) DFNA2/KC/VQ4 families en vergeleken deze met de scores verkregen bij 
een groep DFNA9/COCH patiënten (Hoofdstuk 2.3). Bij overeenkomstige gehoordrempels 
bleken DFNA2/KCNQ4 patiënten betere spraakherkenningscores te hebben dan 
DFNA9/COCH patiënten. Tot op heden zijn er negen ΟΡΝΑ2//<Οι/04 families 
geïdentificeerd, waarvan er vijf afkomstig zijn uit Nederland en België. Dit kan erop wijzen 
dat KCNQ4 mutaties frequenter voorkomen in deze regio. Daarenboven blijkt de mutatie die 
is aangetroffen bij onze familie (W276S) ook de oorzaak te zijn van het gehoorverlies bij een 
andere (hoogst waarschijnlijk) met-gerelateerde Nederlandse en een (hoogst waarschijnlijk) 
met-gerelateerde Japanse familie. Deze mutatie kan aldus beschouwd worden als een 
potentiële hotspot voor mutatie in het KCNQ4 gen. 
Hoofdstuk 3 is het resultaat van een samenwerking met de afdeling Keel-, Neus- en 
Oorheelkunde van de Universiteit Utrecht (Prof Dr EH Huizing) en beschrijft het DFNA5 
fenotype in de - tot op heden - enige gerapporteerde familie met een mutatie in het DFNA5 
gen. Behalve de algemene klinische kenmerken van DFNA5 hebben we ook de vestibulaire 
functie bij het onderzoek betrokken; deze bleek intact te zijn (Hoofdstuk 3.1). Opnieuw 
verzamelden we vooraf verkregen spraakherkenningscores (Hoofdstuk 3.2). Deze bleken 
wederom te passen bij een specifiek hoge-tonen gehoorverlies. De spraakherkenning bij de 
DFNA5 patiënten bleek relatief goed te zijn, zeker gezien de reeds eerder aangetoonde 
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snelle progressie van het gehoorverhes. Bij overeenkomstige drempelwaarden bleken hun 
scores tussen die van de DFNA2/K,C/\/Q4 en de DFNA9/COC/-/ patiënten in te liggen. 
Hoofdstuk 4 beschrijft de klinische kenmerken van ΟΡΝΑ10/£Ύ/44. De algemene 
klinische kenmerken zijn afgeleid uit de fenotypes van de twee families die momenteel 
bekend zijn met DFNM0/EYA4 (Hoofdstuk 4.1). De Otogenetische Groep van de Universiteit 
van Iowa (Prof Dr RJH Smith) had reeds eerder een grote Amerikaanse familie gekoppeld 
aan de DFNA10 locus en bezorgde ons de audiometrische gegevens van deze familie 
(Hoofdstuk 4.2). Uitgebreide analyses van deze gegevens toonden posthnguaal, initieel 
progressief perceptief gehoorverhes dat, zonder de invloed van presbyacusis, resulteert in 
een stabiel vlak verlies. De spraakherkenningscores bleken pas merkbaar te verslechteren 
zodra er sprake was van bijkomende (normale ?) presbyacusis. Later identificeerde de Iowa 
groep het EYA4 gen als het gen dat verantwoordelijk is voor het aan DFNA10 gerelateerde 
gehoorverhes. 
Hoofdstuk 5 spitst zich toe op de klinische karakteristieken van DFNA13/COZ-JM2. 
Het omvat een korte beschrijving van alle families met door DFNA13/COM1A2 veroorzaakt 
gehoorverhes (Hoofdstuk 5.1). Opnieuw zijn audiometrische data verkregen via de groep uit 
Iowa (Prof Dr RJH Smith), die eerder de koppeling met het DFNA13 locus had aangetoond, 
en in dit geval ook al het verantwoordelijke, gemuteerde gen geïdentificeerd had, te weten 
COL11A2 Na analyse kon het perceptief gehoorverhes dat in deze Amerikaanse familie 
voorkomt worden omschreven als waarschijnlijk prelinguaal, met-progressief met 
voornamelijk aantasting van de hoge tonen. 
Samenvattend: de klinische aspecten van de bestudeerde families zijn uitgewerkt en 
in sommige gevallen aangevuld. Het is inderdaad van groot belang om de fenotypes, in 
relatie tot de bijbehorende genotypes, zo gedetailleerd mogelijk te beschrijven. Het 
bestuderen van genotype-fenotype correlaties zal zonder enige twijfel tot een beter begrip 
leiden van de processen die ten grondslag liggen aan het normale gehoor en aan 
gehoorstoornissen. 
Het aantal zogenaamde "doofheidsgenen" neemt nog steeds toe en er kan worden 
verwacht dat nog vele "nieuwe genen" zullen volgen. De betrokkenheid van zo'n diversiteit 
aan genen is, gezien de complexiteit van het auditief systeem, met verwonderlijk. Toch 
ontbreken er nog een heleboel stukjes van de puzzel. Daarom blijft het opsporen en 
analyseren - zowel genetisch als klinisch - van nieuwe families noodzakelijk. Bovendien is bij 
vele genotypes het bijbehorende fenotype nog met, of met nauwkeurig genoeg, beschreven. 
Clinici zouden gestimuleerd moeten worden om deze achterstand in te halen. De 
vooruitgang op het gebied van gehooronderzoek is immers met alleen gebaseerd op 
verbeteringen in onze basale (patho)fysiologische kennis, maar ook op verbeteringen op het 
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klinische vlak. Dit laatste zal leiden tot een verbeterde classificatie van verschillende types 
van erfelijke slechthorendheid, meer inzicht in de epidemiologie, de ontwikkeling van 
moleculair-diagnostische testen, een betere kwaliteit van erfelijkheidsadviezen (counseling) 
en de ontwikkeling van nieuwe behandelingsvormen De moleculair-diagnostische test op 
Connexme 26 mutaties (DFNB1, zie Hoofdstuk 1) behoort ondertussen tot de 
routineprocedure; dit heeft reeds in vele gevallen de oorzaak van slechthorendheid kunnen 
ophelderen. De toekomst zal hoogstwaarschijnlijk screeningsmethoden kennen die de 
mutaties, die slechthorendheid veroorzaken, trefzeker kunnen opsporen, zodat de 
slechthorendheid onmiddellijk gediagnosticeerd en hopelijk ook behandeld kan worden. Een 
ander belangrijk punt is de mogelijkheid om meer inzicht te verkrijgen in de processen die 
verantwoordelijk zijn voor ouderdomsslechthorendheid. 
Het zal duidelijk zijn dat er, hoewel recent aanzienlijke vooruitgang is geboekt, nog 
veel werk zal moeten worden verricht in het kader van het onderzoek naar de onderliggende 
oorzaken van erfelijke slechthorendheid en dat de uitkomsten van dat onderzoek 
verstrekkende gevolgen kunnen hebben voor de medische praktijk van alledag. 
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